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Langerhans cells (LCs) are the unique antigen-presenting cells 
of the mammalian epidermis. They are known to migrate from the 
epidermis into the draining lymph nodes following cutaneous hapten 
application. Several attempts have been made to uncover the 
mechanism(s) of Langerhans' cell (LC) migration. The elucidation of 
the signalling pathway that leads to LC migration is expected to have 
a profound impact on human pathology and therapy. 
Increasing evidence is accumulating for the role of cytokines in 
mediating inflammatory and immune responses within the skin. 
Recent findings suggest that cytokines may also be involved m the 
phenomenon of LC migration following uptake of antigen in the 
epidermis. The purpose of this study was to examine the secretion of 
interleukin(IL)-1-alpha and tumor necrosis factor (TNF)-alpha 
following the stimulation of epidermal cells with staphylococcal 
enterotoxin-A(SEA), a superantigen which induces LC migration. The 
investigations in this study involved specific treatments of epidermal 
cells in suspension, followed by a one-day culture of the cells, after 
which the cell-culture supernatant fluids were ·tested by ELISA for 
the presence of the two cytokines. 
The results indicate that although epidermal cells secrete both 
cytokines constitutively, SEA induces a further increase in the 
secretion mainly of IL-l alpha, and to a lesser extent of TNF-alpha. 
The increase of IL-l alpha is apparently mediated v1a a protein 
kinase C-mediated signal transduction pathway, while its constitutive 
production is affected through G-proteins as well. More specifically, 
there are indications that Langerhans cells are partly responsible for 
the constitutive but not SEA-induced secretion of IL-l alpha while 
other epidermal cells may be the chief source in the latter case. 
Dendritic epidermal T -cells were implicated to be· either a source of 
or serve as inducers of constitutive TNF-alpha secretion in the 
epidermis. 
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The Langerhans cell (LC) is no doubt one of the most intriguing 
cells of the immune system within the skin. It was discovered in 
1868 by Paul Langerhans, who is much better known to medical 
science for his other major discovery - the pancreatic "islet" cells 
(24 ). He described these intraepidermal cells as "a system of sensory 
elements" for carrying "extracutaneous signals to the nervous 
system" (119). For a long time since then the Langerhans cell (LC) 
was believed to be a component of the nervous system that served 
an unknown function. More than a century later, with the recognition 
of vertebrate skin as a complex organ, there was a resurgence of LC 
studies. This rediscovery came about when a group of researchers, 
while investigating the effects of topical estrogen application on 
human skin enzymes, stumbled upon a dendritic cell located in the 
suprabasal layer of the epidermis that was adenosine triphosphatase 
(ATPase) positive (25). This finding laid the foundation of 
morphological and functional studies of the LC. 
It is now known that Langerhans cells (LCs), which constitute 
1-8% of epidermal cells in mammalian skin (25,50,93 ), are bone 
marrow-derived (50) antigen-presenting cells ( 103 ). They are 
located in the basal and suprabasal layers of stratified squamous 
epithelia ( 40,49) like that of the buccal mucosa, vagina, cervix, 
esophagus, and epidermis. LCs form a continuous network with their 
dendrites and play a key role in the induction of primary T -cell-
1 
dependent immune responses m the skin (28,84,109). LCs are 
capable of movement and are 
epidermis (53) to the draining 
(unsensitized) conditions. However, 
constantly migrating from the 
lymph nodes under "normal" 
it has been shown that this 
depletion of LCs in the skin is much more marked at sites of topical 
or intradermal challenge with an antigen or hapten (5,101), or 
ultraviolet light exposure (5, 113 ). Contact hypersensitivity studies 
have shown that antigen-bearing dendritic cells accumulate m the 
lymph nodes following skin sensitization (20,55,56,57, 72). In 
addition flow cytometric analyses have revealed that following the 
application of a chemical a11ergen on skin, a considerable proportion 
of dendritic cells that arrive in the lymph nodes carry the allergen 
(54,55,72). Thus substantial evidence now supports the idea that LCs 
trap antigen m the epidermis and carry it to the draining lymph 
nodes, where they tend to home to T -cell areas (64 ). This is the site 
where the antigen is presented to T -cells in context of major 
histocompatibility complex (MHC) class II molecules (denoted as 
HLA-DR in humans and Ia in mice), which ultimately results in the 
effector function of the immune system. Larsen et al. (1990) have 
shown that the phenotypic and functional maturation of LCs begins 
in the epidermis, but is not completed within it (64). The maturation 
continues through the migratory process. Hence, the epidermis 
represents the primary site for the initiation of immune responses 
within the skin. 
The nature of the stimulus that induces LC migration, the 
intracellular signalling pathway(s), and the mechanism(s) leading to 
sensitization after hapten application are yet to be elucidated 
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(21 ,26,39,49). Investigations m the last decade have revealed that 
epidermal cells are capable of secreting immunoregulatory cytokines 
(67). Under appropriate circumstances epidermal cells can secrete 
the following cytokines: interleukin(IL)-1 ( -alpha,-beta), IL-3, IL-6, 
IL-8, tumor necrosis factor (TNF) ( -alpha,-beta), interferon (-alpha,-
beta), granulocyte colony-stimulating factor (G-CSF), macrophage 
colony-stimulating factor (M-CSF), granulocyte/macrophage colony 
stimulating factor (GM-CSF), transforming growth factor (-alpha,-
beta), basic fibroblast growth factor, platelet-derived growth factor, 
epidermal cell suppressor factor, and epidermal cell-derived contra-
IL-l (66,67 ,96) (see Appendix-!). Although keratinocytes are the 
major source of cytokines within the epidermis, there is ample 
evidence which indicates that LCs are another source of some of 
these immunomodulating factors (67). Cytokines play various roles m 
the activation, differentiation and proliferation of cells (115). Both 
Immune as well as non-immune cells can secrete and react in 
response to cytokines. 
Recently Lundqvist and Back (1990) discovered that an 
intraperitoneal injection of recombinant IL-l-beta caused depletion 
of I a+ cells in murine epidermis (71 ). Further Enk et a!. (1993) 
suggested that dendritic cell-derived IL-l-beta may play a crucial 
role in the initiation of primary immune responses within the skin 
(26). Previously, having demonstrated that an intradermal injection 
of TNF-alpha induces LCs to accumulate in draining lymph nodes, 
Cumberbatch and Kimber (1992) had proposed that TNF-alpha may 
provide one stimulus for LC migration from the skin (21). GM-CSF 
was found to increase viability and enhance the function of LCs in 
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culture (58, 118), and in humans, to promote keratinocyte growth and 
wound healing as well ( 48 ). IL-l alone, on the other hand, does not 
keep LCs alive, but further enhances LC function when combined 
with GM-CSF (44). TNF-alpha was found to maintain LC viability in 
vitro, but no enhancement of LC function was observed (58). 
It is clear that there is a network of interacting cytokines m the 
epidermis (68) and one or more of these may constitute the stimulus 
for LC migration from the skin. However, there are various types of 
cells in the epidermis [LC, Thy-1 + dendritic epidermal T-cells (DETC), 
keratinocytes, melanocytes, merkel cells and indeterminate cells] 
that may be the source(s) of the cytokines. The viability and function 
of LC may be modulated by cytokines through autocrine and 
paracnne regulation within the epidermis. It is vital, therefore, to 
elucidate the migration-inducing cytokine(s) and its source as a 
primary step in our understanding of the Langerhans' cells migratory 
phenomenon. 
lmmunobiology of the Skin 
The skin is the largest organ of the mammalian body. Its 
principal function, that of an impenetrable physicochemical barrier 
to water, water-soluble compounds, and potentially harmful 
microorganisms, was the only function associated with it for ages. 
Other major physiological functions of the skin that were realized 
several decades ago include maintenance of body temperature, 
regulation of stable circulation, production of endocrine mediators, 
and the bearing of peripheral neural receptors and nerve endings 
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(9), which enable perception of sensory stimuli. Hence the central 
role of the skin in host defense has been known for a long time. 
Although the idea that an interaction exists between the skin and 
host immunity has also been recognised for several decades, 
extensive studies of immunity within the skin have been conducted 
only within the last twenty years. Mammalian skin was found to 
contain all the components required for the elicitation, performance, 
and regulation of immune responses to foreign antigens. 
Streilein introduced the term Skin Associated Lymphoid 
Tissues (SALT) in 1978 to depict the special relationship that exists 
between the skin and the immune system (106). The term SALT 
resembles the notions of gut-associated lymphoid tissues (GALT) and 
bronchial-associated lymphoid tissues (BALT) which were 
formulated to signify the major role of the mucosal surfaces of the 
gastrointestinal and respiratory tracts, respectively, m the immune 
defense system. The SALT is a complex of cells that can sort out self 
from non-self (foreign) antigens and allows the skin to react 
autonomously to immune challenges. Besides Langerhans cells five 
other skin cell populations are known to constitute the SALT system. 
These are keratinocytes, T -lymphocytes (T -cells), endothelial cells, 
dermal dendritic cells, and dermal macrophages (1 08). Keratinocytes 
comprise the majority of the epidermis, and are believed to create a 
unique microenvironment that is favorable to antigen uptake and 
lymphocyte function. LCs are the antigen-presenting cells of the 
epidermis while the chief antigen-presenting cells of the dermis are 
the dermal dendritic cells and macrophages. These cells are 
responsible for the uptake, processing, and presentation of antigens 
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to T -cells in situ or m the draining lymph nodes. Almost all 
conventional T -cells (bearing alpha/beta T -cell receptors) are 
confined to the dermis while the majority of lymphocytes in murine 
epidermis are Thy-1 + dendritic epidermal T -cells (DETCs; bearing 
gamma/delta T-cell receptors). A homologue of the Thy-1 + DETC has 
not been conclusively demonstrated in other animals. Nevertheless, 
there is some evidence of the occurrence in low numbers of a similar 
subset of gamma/delta T -cells in humans (38). The exact role of 
DETCs is not completely resolved. There have previously been 
suggestions of a relationship to natural killer (NK) cells (87) or a role 
in the induction of antigen-specific tolerance (107). Recent evidence 
has implicated the involvement of DETCs in cutaneous immunologic 
tolerance (117). Endothelial cells, through the expression of cell 
surface adhesion molecules (CAMs), promote LC and lymphocyte 
migration into dermal lymphatics and from the vasculature into the 
dermal and epidermal compartments. Taken together, the functional 
properties of these diverse cells of the SALT and their their 
cooperative interactions confer upon the skin the ability to recognise 
and distinguish between self and non-self cutaneous antigens, and 
then initiate immune responses which ultimately result in the 
elimination of the foreign antigens. 
The Epidermis 
The epidermis is the most superficial layer of the skin. It is 
avascular and consists of various layers of cells. The uppermost layer 
of human epidermis which is exposed to the external environment, 
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called the stratum corneum (or "horny" layer), 1s composed of flat, 
anucleate, and cornified dead cells. The layer immediately beneath 
the stratum corneum · is the transitional layer or stratum lucidum 
which is usually a single layer of anucleate cells. Below it is the 
stratum granulosum which comprises a couple of layers of granular 
cells. Underlying the granular layer are a few layers of cells 
comprising the stratum spmosum (or spinous layer) below which is 
the basal layer or stratum germinativum (120). The basal layer sits 
upon the basement membrane that separates the dermis from the 
epidermis. These five layers may or may not be easily 
distinguishable depending upon the location of the epidermis on the 
human body. The epidermis of mice Is not structurally comparable to 
that of humans. Murine epidermis is extremely thin and generally 
consists of between 3-4 viable cell layers only. 
The multilayered epidermis encloses an aqueous 
microenvironment between the stratum corneum and the basement 
membrane. The cells of the SALT system mentioned earlier are found 
in the region between the stratum granulosum and the stratum 
germinativum (108). Langerhans cells are particularly found in the 
area near the hair follicle root sheaths. 
Morphology of Langerhans Cells 
Mammalian epidermis consists of three major cell populations: 
keratinocytes, melanocytes, and Langerhans cells. All three 
populations appear as "clear cells" (i.e., cells with nuclei surrounded 
by relatively unstained cytoplasm) in routine paraffin-embedded 
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hematoxylin-and-eosin stained epidermal sections (1 0). LCs are not 
visible by this method ( 40,104, 119). LCs are usually identified by 
special light microscopic techniques involving immunohistological 
stains, and more certainly, by electron microscopy, on the basis of 
specific marker cytoplasmic structures (1 0, 104). 
The most obvious of all LC characteristics that can be viewed 
by light microscopy is their dendritic appearance. The dendrites are 
long and extend three-dimensionally between other epidermal cells. 
The number of dendrites per cell varies upon the location ( 40) and 
perhaps also upon the pathologic conditions. Two most common 
strategies for the identification of murine LCs are to stain for the 
presence of the A TPase marker and for Ia molecules (encoded by 
class II genes of the major histocompatibility complex in mice) on the 
cell surface. These two surface markers are absent on other 
epidermal cells under normal conditions. Epidermal LCs possess high 
amounts of ATPase on their cell surface (4,88,111). In the past the 
A TPase marker was utilized most commonly for the detection of LCs. 
Nevertheless, the loss of this marker under certain pathologic 
conditions made it necessary to use immunochemical staining of the 
Ia molecules (25). LCs also have Ia or 'Immune-response-region-
associated' antigens on their surface (90, 111) which are expressed 
constitutively. LCs are the only cells in the epidermis that are 
capable of MHC-class-11 expression under normal circumstances 
(92, 1 09). Staining for Ia molecules involves the use of either 
monoclonal or polyclonal antibodies. Both these stains can 
successfully be performed on paraffin-embedded, frozen tissue 
sections, as well as on cell suspensions ( 4) prepared from normal 
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epidermis. However, recent investigations of cutaneous 
hypersensitivity have revealed that under pathologic conditions 
other epidermal cells such as keratinocytes may also express Ia 
antigens (25). Thus this strategy of staining may not accurately 
reveal epidermal LC density under certain conditions. 
While the A TPase and Ia markers are most commonly targeted 
for staining LC, the most definitive feature of LCs is the presence of 
the Birbeck or Langerhans' cell-granule. Birbeck or LC-granules are 
rod-like trilaminar cytoplasmic structures ( 49) that can be visualised 
only through electron microscopy ( 40). The granule is usually located 
near the nucleus or golgi apparatus and is believed to be composed 
of limiting membranes that enclose paracrystalline material. The 
origin of the Birbeck granule is still controversial. There are two 
theories regarding its origin. First, that the granule is a kind of 
"endocytic organelle" ( 49) formed from the cell membrane, and 
second, that it originates from the golgi membranes ( 40) since it is 
usually found in close association with the golgi apparatus. The exact 
function of the Birbeck granule is still unknown. Since LCs are the 
unique antigen-presenting cells of the epidermis, it is hypothesized 
that these granules may be associated with the presentation of 
antigens to T -lymphocytes or temporary intracellular storage of 
antigens ( 49). This view was supported by a study in which 
preferential occurrence of LC-granules in the LC at LC-lymphocyte 
contact zones was demonstrated (19). 
Other markers unique to LCs but less often used in histological 
studies of skin are: the T6 (CD I a) and T -200 antigens in humans 
(31 ,80), TL and Ly-5 antigens in mice (65,91 ), the C3 receptor 
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(12,105), the Fc-IgG receptor (105), and the high and low affinity Fe-
IgE receptors in humans ( 6, 7). Despite their limitations, the A TPase-
stain and the Ia-stain are the most frequently used techniques for 
the identification of Langerhans cells in the epidermis. 
Langerhans cells generally lack phagocytic vacuoles and large 
lysosomes. The cytoplasm contains moderate numbers of 
mitochondria, golgi bodies, rough endoplasmic reticulum, and some 
small lysosomes ( 40). They sometimes display networks of 
microfilaments and a prominent system of microtubules (112), both 
of which are characteristics normally seen in motile cells. 
Ontogeny of Langerhans cells 
As mentioned earlier, it was believed for a long time that the 
LC was a component of the nervous system. However, ever since the 
time that LCs were recognized as a component of the immune 
system, it has been thought that they were of bone marrow origin 
like other immunocytes. Today the ontogeny of the LC is no longer in 
question. Over a decade ago, it was demonstrated that LCs are 
derived from and are continuously repopulated by a mobile pool of 
precursor cells which originate in the bone marrow. Katz et al. (1979) 
established this fact through a two-step experimental process (50). 
First, they transplanted sex-matched parental skin on to hybrid mice 
and after various time periods found MHC class I and class II 
antigens of the recipient on the LCs within the graft. Next, after 
irradiating chimeric mice (where recepient bone marrow cells are 
killed followed by reconstitution with allogeneic or semi-allogeneic 
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bone marrow cells), they found that a low percentage of F c- I g G 
bearing cells in the transplanted skin were of bone marrow-donor 
origin (LC) while the majority of the cells were of the recipient type 
(other epidermal cells). The first experiment showed that the LC of 
the transplanted skin were derived from a mobile pool of recipient 
cells; the latter experiment proved that the LCs were bone marrow-
derived. Since this discovery, Langerhans cells are believed to be of 
the monocyte/macrophage lineage (89). It is interesting, however, 
that no cells in the bone marrow show the presence of Birbeck 
granules (112). Perhaps they are formed during the process of 
differentiation from a macrophage-like or monocyte-like progenitor. 
Functions of Langerhans Cells 
Antigen presentation: 
There IS no longer any doubt about the antigen-presentation 
function of Langerhans cells. An antigen-presenting cell is any cell 
that can pick up, process, and present antigen m association with 
MHC-class-11 molecules to helper T-lymphocytes (TH cells). Strong in 
vitro evidence has shown that LCs are important in this process 
(1 03) lending support to suggestions that LCs may have a function 
similar to that of macrophages (37,112). Langerhans cells were 
demonstrated by Grabbe et al. (1991) to be capable of presenting 
tumor antigens (36). In addition, other in vitro experiments have 
demonstrated that LCs are potent accessory cells in T -helper-cell 
responses ( 49). Accessory cells are those which help or cooperate 
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with T lymphocytes and enable them m the recognition and 
ultimately in the removal of antigens from the body. Langerhans 
cells cultured for 2-3 days exhibit markedly enhanced T -cell-
stimulatory ability (94) and antigen-presenting capacity ( 47 ,99) 
while endocytosis occurs with significantly lower efficiency (34) 
when compared with fresh LCs. 
The precise antigen-processing pathway 1s still unknown. In 
human Langerhans cells, surface MHC-class-II (HLA-DR) molecules 
were shown by Hanau et al. (1987) to cointernalize with T6 (CDla) 
antigens through common coated regions of the cell membrane when 
treated with anti-Ia antibody (41). This cointernalization was 
demonstrated to be due to receptor-mediated endocytosis, which was 
characterized by the presence of coated pits, coated vesicles, 
receptosomes, lysosomes and Birbeck granules (41). Since MHC-class-
11 molecules are involved in binding processed antigens prior to 
antigen presentation, it is possible that antigens may be picked up by 
LCs in a similar manner. The presence of complement receptors 
(12,105) and Fe receptors (6,7,78,105) on LCs may be involved in 
enhancing adherence and the subsequent opsonization of bacteria 
(ingestion of antibody-coated bacteria). A complement receptor is a 
member of a family of cell surface receptors that specifically 
recognize a component of the complement system. Complement is a 
group of serum proteins (Cl-C9) that participate in an enzymatic 
cascade that ultimately generates the cytolytic membrane attack 
complex (62). The complement cascade is activated by antigen-bound 
antibodies of the lgG and lgM isotypes (immune complexes). Once 
complexed with antigen, the Fe portion of the antibody molecule 
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undergoes a conformational change that allows it to bind to the Fe 
receptor on a cell or to the C1 component of the complement system. 
The subsequent reactions of the complement cascade produce an 
enzyme that converts a proenzyme called C3 into the active form C3b 
which is bound to the antigen via the antibody molecule. C3b can 
bind to the C3 receptor on phagocytes such as macrophages, 
monocytes, and neutrophils. On the other hand, the Fe portion of the 
antibodies in immune complexes can directly bind Ig-Fc receptors on 
the phagocytes. In this manner both C3 and antibody Fe portions 
facilitate the recognition and uptake of antigen by phagocytes. 
LCs are very potent antigen-presenting cells, as measured 
through T -cell proliferation assays. They have been shown to be 
more potent antigen-presenting cells on a per cell basis than 
monocytes in responses to antigens frequently found in the skin such 
as those from mycobacteria, Candida albicans, or tetanus toxin (49). 
The main aspect of LC function presented above has been well 
accepted for a long time. However, whether antigen-presentation 
occurs in the epidermis or LCs migrate to the lymph nodes for this 
purpose have been topics of debate for several years. It is widely 
believed that, following hapten sensitization, LCs migrate from the 
skin as "veiled cells" into the draining lymph nodes through the 
lymphatics in the dermis (115). The most convincing evidence for 
this hypothesis came when Kripke et al. ( 1990) showed that 
sensitization of nude mice at the site of a skin allograft leads to the 
appearance of antigen-bearing dendritic cells of donor origin in the 
recepient's lymph nodes (61 ). On the other hand, few other 
researchers hold the view that antigen presentation occurs in the 
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epidermis and that the apparent dissappearance of LCs in tissue 
sections is due to the loss of surface markers and/or cell death. 
Mommaas et al. ( 1993) have recently shown that LC depletion 
following UVB exposure is not due to migration of LCs, but due to cell 
destruction (76). This is in contrast to the results of Moodycliffe et al. 
(1992) which indicated that LCs migrate following UVB exposure 
(77). 
It seems likely that both of the above phenomena might be 
taking place in antigen-chaiienged skin, depending on the type and 
amount of antigen present. 
LC and contact (delayed type) hypersensitivity: 
Much of the knowledge of LC function has been elucidated 
through the studies of the induction or sensitization stage of contact 
hypersensitivity. Such responses develop 48-72 hours following 
activation of a subset of helper T -cells (TH 1) by a hapten (or contact 
sensitizer). A hapten is a low-molecular-weight compound that lacks 
antigenic determinants but can elicit Immune responses when 
coupled to a carrier such as dinitrophenol (DNP). This results in the 
secretion of various cytokines such as interleukin-2 (IL-2), 
interferon(IFN)-gamma, macrophage inhibition factor (MIF) and TNF-
beta (63). The ultimate consequence of this type of reaction is 
localized non-specific enzymatic lysis of infected cells, and usually 
some uninfected neighboring cells as well, by activated macrophages. 
A vast amount of evidence indicates that LCs play a dominant role in 
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the process by which the immune system IS exposed to skin-borne 
antigens and in its responses to them (83). 
Situated within the epidermis, LCs provide a continuous 
network of dendritic processes that can capture antigens 
subsequently leading to processing and presentation of the antigens. 
After challenge with a hapten, the following changes in the LC were 
noted by Silberberg-Sinakin and Thorbecke (1980): the hapten is 
localized on the LC surface and within membrane-bound organelles 
in the LC, and, prominent endoplasmic reticulum, golgi bodies, and 
lysosomes are present indicating increased LC activity (101 ). 
Following this phase, LCs gradually start to dissappear from the 
epidermis ( 49). 
LC and cutaneous immunologic tolerance: 
Topical application of haptens at areas lacking or naturally 
deficient in LCs (such as mouse tail) does not promote induction of 
contact hypersensitivity (109), but instead leads to antigen-specific 
unresponsiveness or tolerance. This suggested that LCs do not 
themselves induce tolerance; it is their absence that leads to it. Later 
studies have implicated the Thy-1 dendritic epidermal T -cells as 
responsible for the induction of immunologic tolerance in vivo (117). 
LC and graft rejection: 
LCs are believed to be critical "passenger leukocytes" (64) that 
trigger graft rejection by sensitizing the recipient's T -cells. It is 
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assumed that epidermal LCs from skin allografts migrate into the 
draining lymph nodes and initiate the rejection. LCs migrate out of 
both allografts and isografts; however, in the case of an allograft, the 
entry of the donor's LCs into the recepient's lymph nodes itself 
provides a powerful stimulus for the initiation of rejection (64). 
LC and allergy: 
Bruynzeel-Koomen et a!. (1986) first reported the occurrence of 
IgE on epidermal LCs in patients with atopic dermatitis, implying 
that LCs may play a key role in the pathophysiology of atopic disease 
(11 ). The majority of resident LCs in human epidermis can bind 
monomeric IgE through the high affinity receptor, Fc-epsilon-RI 
(116). Although the mechanism of signal transduction through cross-
linked LC-surface IgE and its effects are unknown, Wang et al. (1992) 
suggested that it is conceivable that this could stimulate events in 
LCs similar to those occurring in mast cells and basophils (116). 
Under appropriate stimulation (cross-linking of surface lgE by 
allergens) mast cells and basophils are known to synthesize and 
secrete vanous inflammatory metabolites ("degranulation") and 
cytokines (63 ). 
Mudde et al. (1990) showed that lgE-bearing LCs are supenor 
in their ability to present air-borne-house-dust allergens to 
sensitized T -cells in vitro when compared with LCs without surface 
IgE (78). These in vitro results correlate with the positive delayed 
patch reaction to the same allergens indicating that the Fc-epsilon-RI, 
when bound to monomeric IgE, appears to play a crucial role in the 
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uptake and processing of cutaneous antigens by Langerhans cells. 
Targeting this Fe-IgE receptor on LCs may be an important route in 
the future for topical therapy of atopic allergy. 
Epidermal Cytokines 
The discovery of the ability of epidermal cells to secrete 
immunomodulating cytokines further supported the notion that the 
epidermis is a primary site for the induction of immune responses 
within the skin. Cytokines are low-molecular-weight, hormone-like 
proteins which are produced by various cells and can regulate cell 
growth and differentiation. They can exert their biological effects at 
extremely low concentrations via specific surface receptors on target 
cells. The secretion of cytokines mediates immunologic and 
inflammatory reactions. In the epidermis keratinocytes, Langerhans 
cells, and to a lesser extent melanocytes, are known to produce 
cytokines; however, keratinocytes are the major source (66). Through 
the secretion of cytokines epidermal cells are capable of exerting 
autocrine, paracrine, and endocrine effects. Most cytokines have 
multiple effects and have overlapping activities; some are known to 
induce each other (23,51) and also influence cell function in a 
synergistic or antagonistic fashion (68). In recent years it has been 
found that epidermal cells can produce constitutively, or can be 
induced to produce, a wide variety of cytokines. The repertoire of 
epidermal-cell-derived cytokines currently known were listed 
earlier in this chapter (also see Appendix-!). Among these cytokines, 
those that are most important for LC maintenance and function are 
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IL-l (36,44,60,71), GM-CSF (44,48,118), and TNF-alpha (21,58,59). 
Recent studies have investigated the influence of other epidermal-
cell-derived cytokines such as IFN-gamma (84), IL-10 (27), and TGF-
beta (29,36) on LC function. The cytokines IL-l and TNF are 
described in some detail in the following sections. 
Interleukin-1 (IL-l) 
The first cytokine demonstrated to be released by murine 
keratinocytes was epidermal-cell-derived thymocyte-activating 
factor (ET AF), which was also found to enhance ( costimulate) the 
proliferative response of thymocytes to mitogens (69). ETAF was 
soon found to be biochemically and biologically identical to 
interleukin-1 (70). The sources of IL-l were originally thought to be 
cells of the monocyte/macrophage lineage. Within the last decade 
several other cell types were found to produce IL-l (81 ). Two forms 
of interleukin-1, IL-l-alpha and IL-l-beta, which are encoded by 
two distinct genes, have been identified (81 ). Although there is only 
about 26% amino-acid-sequence similarity between these two forms 
in humans (73 ), they recognise the same cell receptor and share the 
same spectrum of biological activities (22,66). IL-l is produced in 
response to damaging stimuli such as infection, ultraviolet 
irradiation, microbial toxins, inflammatory agents, products of 
activated lymphocytes, complement, and clotting components (22). 
Interleukin-1 is multifunctional and exerts both immunological and 
non-immunological effects. Its most important biological effects are 
that it is an endogenous pyrogen (a fever-inducing agent), induces 
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the production of hepatic acute phase proteins, causes neutrophilia, 
activates T -cells, costimulates T -cell mitogenesis, and induces 
cytokine production such as IL-2, IL-4, IFN-gamma, and CSF by T-
cells (22,66). It is also an activator for dendritic cells and seems to 
enhance their capacity to bind to T-cells (102). IL-l induces the 
expression of intercellular adhesion molecules (ICAMs) which enable 
adherence of cells (67). 
IL-l is present in significant amounts in the stratum corneum 
(33) and normal skin ( 43) in humans. Keratinocytes are capable of 
constitutive IL-l production, albeit in low amounts (68). IL-l-alpha 
is the predominant form in the skin (97). 
Tumor Necrosis Factor (TNF) 
Tumor necrosis factor was originally described as a substance 
found in the serum of bacillus Calmette-Guerin (BCG)-infected mice 
treated with endotoxin that mimicked the tumor necrotic action of 
endotoxin itself (14). TNF exists in two forms, TNF-alpha (cachectin) 
and TNF-beta (lymphotoxin), which are antigenically distinct 
polypeptides, but bind a common cell receptor and share common 
biological properties (68). Like interleukin-1, TNF is an endogenous 
pyrogen (23), it can activate neutrophils, and induces the production 
of other cytokines such as GM-CSF, M-CSF, and IL-l (51). TNF-alpha 
can be induced by stimulants such as bacterial endotoxins, ultraviolet 
irradiation, IL-l, and TNF -alpha itself (68). TNF-alpha IS known to 
exert pleitropic biological effects. It ts an important mediator of 
cachexia (characterized by tissue wasting, negative nitrogen balance, 
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and loss of body weight) and endotoxic shock (commonly 
characterized by fever, hypotension, and diarrhoea) (16), and causes 
cytotoxicity and cytostasis of tumor cell lines in vitro (110). 
Within the epidermis, keratinocytes have been demonstrated 
to synthesize and release TNF-alpha upon stimulation (59). TNF-
alpha increases the expression of MHC class-! and class-11 molecules 
as well as intercellular adhesion molecule-1 (I CAM -1) on several cell 
types (68). 
Cytokine-Mediated Maintenance, Maturation 
and Migration of Langerhans Cells 
Because Langerhans cells are antigen-presenting cells stationed 
m the outer layer of the skin and upon antigenic challenge are able 
to migrate to the lymph nodes (to present antigen to T -lymphocytes), 
it is important that they are maintained at a particular density in the 
skin under normal conditions. This homeostasis Is believed to be 
regulated by cytokines, which may be produced by LCs (autocrine 
regulation) and other epidermal cells (paracrine regulation). If cell 
culture studies are assumed to approximately reflect in vivo cell 
growth, then both granulocyte and macrophage colony stimulating 
factor (GM-CSF) and tumor necrosis factor (TNF)-alpha are required 
for maintaining viability of LCs. Schuler and Steinman (1985) 
suggested that epidermal LCs represent precursors or immature 
elements of the dendritic cell system (94 ). However, following 24-72 
hours of in vitro culture of epidermal cell suspensions LCs undergo 




culture, expressing several 
dendritic cells. Since LC 
new features unique to 
maturation leads to the 
development of accessory function (118) for pnmary Immune 
responses, the regulation of maturation following skin sensitization 
(or antigenic challenge) becomes very important. Changes in LCs due 
to maturation in vitro include decrease in antigen uptake ability, loss 
of antigen processing ability, decrease in the number of LC granules 
(86), and increase in lymphocyte stimulatory ability. 
Koch et al. (1990) showed that both GM-CSF and TNF-alpha can 
maintain LC viability in culture, but unlike GM-CSF, TNF-alpha cannot 
induce maturation of LC function (58). Interleukin-1 (IL-l) on the 
other hand does not maintain viability. but enhances LC function 
two-fold when combined with GM-CSF (58). The stimulus that causes 
LCs to migrate from the skin, however, remains to be elucidated. 
Some researchers have suggested that IL-l may be this stimulus 
(71) while some others believe that TNF-alpha is responsible for LC 
migration (21). 
An unpublished work of Pickard and Burnham (85) had 
previously shown that the superantigens Staphylococcal enterotoxin-
A (SEA), Staphylococcal enterotoxin-B. and Staphylococcal exfoliative 
toxin are capable of inducing a dose-dependent depletion of 
Langerhans cells in murine epidermis. Among these SEA proved to 
stimulate the most drammatic depletion of LCs. Staphylococcal 
exotoxins are known to deliver activation signals via Ia similar to 
that produced by the binding of anti-Ia monoclonal antibody (17). 
Unlike nominal antigens, SEA interacts with MHC-class-11 (Ia) 
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molecules at a site independent of that involved m antigen 
presentation, and is also capable of binding the T -cell receptor (TCR). 
Superantigens like SEA can thus mediate the interaction between 
antigen-presenting cells (APC) and T -cells without being internally 
processed by APC. This interaction leads to the antigen-non-specific 
activation of T -cells. Since LCs are the only cell type capable of 
expressmg Ia in normal murine epidermis and since superantigens 
are known to interact with surface MHC-class-11 (Ia) molecules, it IS 
reasonable to assume that the LC depletion induced by SEA is 
mediated by activation through Ia. Although SEA produces higher 
quantitative responses by epidermal cells it probably produces 
events qualitatively similar to those induced by nominal antigens, 
since nominal antigens also interact with MHC-class-11 molecules and 
play a role m the activation of antigen-specific T -cells. 
Since both IL-l and TNF have been implicated to play a crucial 
role in the migration of LCs from the epidermis, the present study 
examines their secretion by epidermal cells and their subpopulations 
induced by SEA. The intention of this approach was that an 
investigation of the depletion-inducing stimuli and molecular-
signalling pathway(s) involved in SEA-induced LC depletion may 
later serve as a model for the signalling pathway(s) and 
mechanism(s) of LC depletion or migration caused by nominal 
antigens in the skin. Such studies may have a profound impact on 
human pathology and therapy. Such knowledge may allow us to 
manipulate LC function to obtain desirable immune responses (such 
as tolerance) and prevent undesirable effects (such as allergies). 
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CHAPTER II 
MATERIALS AND METHODS 
Animals 
Young adult (6-to-8 weeks old) female BALB/c strain mice 
obtained from Charles River (Wilmington, MA) were used throughout 
this study. The mice were maintained in a licensed facility at 
Oklahoma State University. 
Buffers and Media 
Balanced salt solution (BSS, without calcium and magnesium) 
was used to keep surgically-removed skin hydrated at room 
temperature. One liter of BSS contains 8.0 g sodium chloride (NaCl, 
Baker Chemical Corp., Phillipsburg, NJ), 0.35 g sodium bicarbonate 
(NaHC0 3, Mallinckrodt, Paris, KY), 0.4 g potassium chloride (KCl, 
Fisher, Fairlawn, NJ), 1.0 g glucose (Fisher), and 0.2% phenol red 
(Difco, Detroit, Ml) in deionized water. 
Phosphate buffered saline (PBS, 0.15 M) was utilized to prepare 
solutions of trypsin (type II, from porcine pancreas, Sigma Chemical 
Company, St.Louis, MO) and deoxyribonuclease I (DNase I, from 
bovine pancreas, Sigma). One liter of PBS contains 1.15 g anhydrous 
sodium phosphate (N a2H P 0 4 , Sigma), 0.2 g monobasic potassium 
phosphate (KH2P04, Fisher), 8.0 g NaCl, and 0.2 g KCI in deionized 
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water. The pH of the solution was adjusted to 7.2 prior to sterilization 
in an autoclave at 15 psi for 20 minutes. 
In all experiments, cells were washed and cultured in Cellgro™ 
sterile RPMI 1640 (Mediatech, Washington, DC) supplemented with 
10% fetal bovine serum (PBS, Atlanta Biologicals, Norcross, GA), 2 mM 
L-glutamine (Sigma), 100 U/ml penicillin (Sigma), and 0.1 mg/ml 
streptomycin (Sigma). 
Cytotoxicity medium recommended by Cedarlane Laboratories 
(Ontario, Canada) was used in complement-mediated epidermal-cell-
subpopulation depletion experiments. One liter of this medium 
contained 10.4 g powdered RPMI 1640 (Sigma), 25 mM HEPES 
(Sigma), 0.3% bovine serum albumin (BSA, fraction V, Sigma), 1 mM 
sodium pyruvate (Sigma), 0.22% Sodium bicarbonate, 2 mM L-
glutamine, 0.1 mM non-essential ammo acids (Sigma), 100 U/ml 
penicillin, and 0.1 mg/ml streptomycin in deionized water. The 
medium was filtered through a 0.45 micron filter (Corning Inc., 
Corning, NY) and stored at 4°C till required. 
Toxins and Chemicals 
Staphylococcal enterotoxin A (SEA, Toxin Technology, Sarasota, 
FL) and Lipopolysaccharide (LPS, Sigma) were applied to epidermal 
cells in some experiments to induce cytokine production. 
Inhibitors of signal transduction in this study included 1-(5-
isoquinolinylsulfonyl)-2-methylpiperazine (H-7, an inhibitor of 
protein kinase C, Calbiochem Corp., San Diego, CA) (45,52), N-[2-
(methylamino) ethyl] -5-isoquinoline sulfonamide (H-8, an inhibitor 
24 
of G-protein associated cyclic-nucleotide-dependent protein kinases, 
Calbiochem Corp.) ( 45), and Cholera and Pertussis toxins (inhibitors 
of separate G-proteins, Sigma) (114). 
Antibodies 
Purified mouse-anti-mouse-lad monoclonal antibody 
(Pharmingen, San Diego, CA) was used for several purposes in this 
study. It was applied as a treatment in some experiments, m 
experiments requiring complement-mediated depletion of 
Langerhans cells, and in the separation of Langerhans cells from 
epidermal cell suspensions usmg the biomagnetic separation 
technique described later in this chapter. This monoclonal antibody 
(mAb) is of the IgG isotype and is specific for the mouse MHC-class-
11 (Ia) cell surface antigen encoded in the 1-A region of the H-2d 
haplotype. The hybridoma J1j10 (anti Thy 1.2) [American Type 
Culture Collection (ATCC), Rockville, MD] was -cultured m 
supplemented RPMI 1640 and the cell-free supernatant was 
collected and stored at -20 °C. This supernatant contained a rat IgM 
monoclonal antibody specific for the Thy-1 antigen on the surface of 
munne T lymphocytes. Another hybridoma, R4-6A2 (anti munne 
gamma interferon) (ATCC) was also cultured and stored in an 
identical manner. This hybridoma secretes a monoclonal rat IgG that 
was used to neutralize IFN -gamma in some experiments. 
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Preparation of Epidermal Cell 
Suspensions 
Following hair removal, mice were euthanized in an ether 
chamber. Total body skin was surgically removed, cut into large 
pieces, and kept hydrated with BSS at room temperature till 
required. Ears were split with the aid of fine-tipped foreceps and 
floated, dermal side down, on a freshly prepared solution of 0.5% 
trypsin for 45 min at 37°C in the presence of 5% carbon dioxide. 
After scraping away the subcutaneous layer, pieces of skin were also 
placed dermal side down on 0.5% trypsin and incubated for 35 min 
under the same conditions. Following incubation, the loosened 
epidermal sheets were carefully peeled from the ears and skin and 
laid dermal side up on the surface of a clean plastic Petri dish. The 
exposed basal layer of the epidermis was immediately covered with 
a solution of 0.05% DNase I and gently rubbed with the smooth tip of 
a glass stirring rod to bring epidermal cells into suspension. 
Approximately four volumes of supplemented RPMI 1640 were 
added to the suspension and filtered through a Falcon™ 100 urn 
sterile nylon mesh (Becton Dickinson, Franklin Lakes, NJ) to remove 
clumps. The cells were pelleted by spinning at 300Xg for 5 min at 4°C 
in a Damon CRU-5000 centrifuge (IEC, Needham Heights, MA) and 
washed twice with culture medium (supplemented RPMI 1640) to 
remove all DNase I. After the final wash the cells were resuspended 
in 10 ml culture medium, counted by trypan blue (Sigma) exclusion 
with the aid of a hemacytometer, and adjusted to the required 
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air. Following incubation, the culture medium was collected, spun at 
300Xg for 5 min to pellet the cells, and stored in aliquots at -70°C till 
required. 
Purification of Langerhans Cells by 
Biomagnetic Separation 
An epidermal-cell suspension was prepared in supplemented 
RPMI 1640 (culture medium), washed twice, and counted by trypan-
blue exclusion. The cells were sedimented at 300Xg and resuspended 
at 1 X 107 cells/ml with 5 ug anti-Ia mAb/ml of 10% PBS (in PBS). 
They were incubated at 4°C for 40 min with gentle bidirectional 
shaking on a tube rotator. Subsequently, the cells were washed three 
times with cold culture medium to remove all unbound antibody, and 
adjusted to a concentration of 2.5 X 107 cells/ml of culture medium. 
A pre-calculated number of sheep-anti-mouse IgG-coated magnetic 
beads (Dynal, Inc., Lake Success, NY) were taken in a separate test 
tube and washed at least three times in culture medium (this 
number was calculated assuming that about 3% of the EC suspension 
consisted of Langerhans cells). Washing the beads was accomplished 
by placing the tube on a Dynal magnetic particle concentrator (MPC) 
and, following a 2 min standing period to allow the beads to adhere 
to the wall of the tube closer to the magnet of the MPC, the medium 
was collected with a sterile pasteur pipette and discarded. This step 
was essential to remove all traces of the preservative sodium azide 
that was included in the commercial magnetic-bead suspension for 
storage purposes. The magnetic beads were then added to the highly 
concentrated cell suspension so that there were about 15 beads per 
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target cell, which is a significantly high bead-to-cell ratio to allow 
optimal cell/bead interaction. The test tube containing the cell-bead 
mixture was incubated at 4°C for 40 min on a tube rotator. All the 
incubations thus far were done at 4°C to minimize non-specific 
adherence. 
The binding of beads to the anti-Ia-bound cells resulted in 
rosette formation. Following the last incubation, the rosettes (LCs) 
and free beads were separated from non-rosetted cells (other 
epidermal cells, OECs) by using the MPC as described above. While 
rosetted cells were bound to the wall of the tube closer to the magnet 
of the MPC the non-rosetted cells were removed with a sterile 
pasteur pipette into a separate test tube. The fraction containing 
rosettes (LCs) was washed at least three times with cold culture 
medium to ensure that all non-rosetted cells (OECs) were removed. 
To ensure that all LCs were removed from the OEC fraction, the MPC 
was applied to it twice as described above. Finally, the number of 
cells in each of the two fractions was determined and adjusted to 
appropriate concentrations as required. SEA was then applied to 
some fractions, and the cells were incubated for 24 h at 37°C in the 
presence of 5% carbon dioxide. Cell-free supernatant fluids were 
collected as described earlier, aliqouted, and stored at -70°C till 
required. 
Cytokine Assays 
IL-l-alpha and TNF-alpha were assayed using commercially 
prepared Intertest-1 alpha X™ ELISA and Factor-Test-X™ ELISA kits 
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(Genzyme, Cambridge, MA) respectively. The traditional methods 
used for IL-l and TNF detection are bioassays. The thymocyte co-
stimulator assay is used for IL-l while the L929 killing assay is used 
for TNF. Both of these assays require 2-3 days for completion. These 
assays are also unable to differentiate between the two forms of each 
of these cytokines. The kits, on the other hand, require only 3-4 
hours for cytokine quantitation and are specific for murine IL-l-
alpha and TNF-alpha. The assays were done by sandwich ELISA, for 
which all reagents were included in the kits. 
IL-l-alpha ELISA: 
The kit contained anti-mouse IL-l-alpha mAb pre-coated 
wells, which required blocking prior to sample incubation. Blocking 
with an unrelated protein solution prevents non-specific binding of 
antigen to the wells. One hundred microliter samples were added to 
the wells and incubated to allow binding of IL-l-alpha to the anti-
IL-l-alpha mAb. Subsequently biotinylated polyclonal anti-mouse 
IL-l-alpha was added to the wells. Following this incubation, avidin-
conjugated peroxidase was added to the wells and incubated once 
again, to allow it to bind to biotin. Finally, a substrate solution 
containing tetramethylbenzidine (TMB) and buffered hydrogen 
peroxide was added. In between all of the above steps, the wells 
were washed four times with wash buffer. The substrate reaction 
was allowed to occur at room temperature for a fixed period of time 
and then halted by adding an equal volume of 1 M sulfuric acid (stop 
reagent). The ELISA reader (Vmax™ kinetic microplate reader, 
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Molecular Devices Corp., Palo Alto, CA) was blanked usmg culture 
medium (containing no IL-l-alpha) and the absorbance of the 
samples was read at 450 nm. 
TNF-alpha ELISA: 
The kit contained hamster-anti-mouse TNF-alpha mAb pre-
coated wells. One hundred microliter samples were incubated in the 
wells to allow binding of TNF-alpha to the antibody. Following four 
washes with wash buffer, horseradish peroxidase-conjugated goat 
polyclonal anti-mouse TNF-alpha was added and the incubation was 
continued. Subsequently, the wells were washed four times and a 
substrate solution containing TMB and buffered hydrogen peroxide 
was added. The substrate reaction was allowed to occur at room 
temperature for a fixed period of time and then stopped by adding 
an equal volume of stop reagent. As in the IL-l-alpha assay, 
absorbances were read at 450 nm after blanking the ELISA reader 




The objective of the present study was to examme the 
secretion of IL-l-alpha and TNF-alpha by epidermal cells (ECs) and 
epidermal-cell- subpopulations when stimulated by Staphylococcal 
enterotoxin-A (SEA). Staphylococcal exotoxins such as SEA are known 
to deliver activation signals via cell-surface Ia similar to that 
produced by the binding of anti-Ia monoclonal antibody (17). The 
data obtained from two separate experiments are shown for each 
investigation and the standard error of the mean (SEM) was 
calculated in order to interpret the significance of the results. 
Effects of SEA and Lipopolysaccharide (LPS) 
on EC Cytokine Secretion 
In order to ascertain the unique stimulatory action of SEA, its 
ability to induce cytokine secretion by ECs was compared with that of 
LPS, a bacterial cell wall component and a common endotoxin. SEA 
and LPS were applied to EC suspensions at concentrations of 5 ug/ml 
and 100 ug/ml respectively and the cells were incubated for 24 h at 
3 7°C in the presence of 5% carbon dioxide. Subsequently, the cell-
free culture supernatant fluids were obtained by pelleting the cells 
at 300Xg for 5 min and analyzed for IL-l-alpha and TNF-alpha levels 
by ELISA. Figures 1 and 2 depict the results of two such experiments. 

















• Control ,. SEA II LPS 
~ SEA+LPS 
Figure 1. Comparison of the increases in IL-l 
-alpha secretion by epidermal cells following 
stimulation with SEA and LPS. The values 
expressed are the mean + SEM (standard 
error of the mean) generated by pooling 
the data from two separate experiments. 
(LPS- lipopolysaccharide; SEA-staphylo-
















• Control tJI SEA II LPS 
~ SEA+LPS 
Figure 2. Comparison of the effects of SEA and 
LPS on TNF-alpha secretion by epidermal 
cells. The values expressed are the mean + 
SEM generated by pooling the data from two 
separate experiments. 
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alpha secretion by ECs. LPS was also capable of stimulating an 
increase in IL-l-alpha secretion, but to a lesser extent. However, it 
was discovered that when applied simultaneously, SEA and LPS acted 
in a synergistic fashion. They induced a massive increase in EC-
secreted IL-l-alpha which was greater than the sum of the effects of 
each taken independently. Figure 2 shows the influences of SEA and 
LPS on the secretion of TNF-alpha by ECs. There was a small increase 
of TNF-alpha when induced by SEA. Surprisingly, however, LPS by 
itself caused a considerable decrease in TNF-alpha secretion and also 
blocked the action of SEA on the EC suspension. These results 
demonstrate an increase in IL-l-alpha secretion by ECs following 
stimulation with SEA, which is more marked than that induced by 
LPS. 
Effect of SEA on Langerhans' Cell Morphology 
The morphology of LCs in normal epidermis and following SEA 
application on the extracutaneous surface are shown in Figures 3 and 
4. Visualization of LCs was enabled through an Ia stain which stains 
all cells in the epidermis that express cell-surface MHC-class-11 
molecules. Under normal conditions, LCs appeared to have dendrites 
extended out from the cell body. However, the application of SEA 
followed by a 48 h incubation caused a notable difference in LC 
morphology m addition to a decrease in LC density observed 
previously (85). Under stimulation by SEA, LCs appeared round in 
shape and the dendrites were not visible. This suggests that the LCs 
either retracted their dendritic processes or that their surface Ia 
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Figure 3. Normal morphology of Langerhans cells 
in the epidermis. Arrows indicate dendritic 
processes of one Langerhans cell. 
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Figure 4. Effect of extracutaneous SEA application 
on the morphology of Langerhans cells in the 
epidermis. Arrows indicate stained LCs. 
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molecules were clustered together over the cell body. Such an 
aggregate of Ia molecules would produce a rounded appearance after 
the Ia stain. In either case, it is evident that SEA induces not only a 
change in cytokine secretion but also in LC morphology. 
Role of G-proteins and Second Messengers 
Involved in the Transduction of the 
SEA-induced Stimulus 
Extracellular stimuli such as the binding of biochemical 
transmitters, cytokines, or hormones to their corresponding cellular 
receptors ("signals") are known to be converted into intracellular 
events by complex, and yet highly regulated, signal transduction 
pathways. Such pathways are usually composed of signal transducers 
(GTP-binding proteins; alternatively called G-proteins), enzymes 
(adenylate cyclase or phosphoinositide-specific phospholipase C), and 
second messengers (cyclic AMP or calcium-dependent protein kinase 
C) that interact with each other near the cytoplasmic end of a cell-
surface receptor to produce the intracellular event or change in cell 
behaviour. 
In order to investigate the role of G-proteins and second 
messengers in the secretion of IL-l-alpha and TNF-alpha, inhibitors 
of signal transduction were examined for their capacity to block 
secretion of these cytokines. This was accomplished by culturing 
epidermal-cell (EC) suspensions with H-7, H-8, Cholera toxin, or 
Pertussis toxin for 1 h at 37°C prior to the addition of SEA. Following 
the addition of SEA to some groups, the cells were further incubated 
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for 24 h. 1-(5-isoquinolinylsulfonyl)-2-methylpiperazine (H-7) was 
employed because of its property to inhibit the function of protein 
kinase C (52). N-[2-(methylamino) ethyl]-5-isoquinoline sulfonamide 
(H-8) is known to specifically inhibit G-protein-associated kinases 
(45). Purified toxins from V.cholerae and B .pertussis were employed 
to further examine the role of G-proteins. These two toxins are 
inhibitors of distinct but overlapping spectra of G-proteins (114). H-7 
and H-8 were applied at a final concentration of 10 uM while cholera 
and pertussis toxins were applied at a final concentration of 1 ug/ml 
to EC suspensions. Following the 24 h incubation, cell culture 
supernatants were tested by ELISA for IL-l-alpha and TNF-alpha 
levels. Results of this study are illustrated in Figures 5 and 6. While 
the constitutive IL-l-alpha levels were significantly lowered by all 
the inhibitors, the application of SEA to EC suspensions containing H-
8, cholera toxin (CT), and pertussis toxin (PT) resulted in an 
approximate 100% increase in IL-l-alpha, identical to that seen 
when SEA was applied in their absence (Figure 5). Thus all the 
inhibitors of signal transduction were able to block constitutive IL-l-
alpha secretion while only H-7 was efficient in blocking the SEA-
induced IL-l-alpha level as well. These data implicate protein kinase 
C as the second messenger (and hence phospholipase C as the effector 
enzyme) that mediates increased IL-l-alpha secretion following 
stimulation with SEA. On the other hand, the results indicate that 
constitutive IL-l-alpha secretion involves both G-proteins and 
protein kinase C. There was a small increase in TNF-alpha production 
induced by SEA, which was not significantly blocked by any of the 




















D H-8 • 
r:a PT D 
Treatments 
fij SEA II H-7 ~ SEA+ H-7 
SEA+H-8 ~ Cf [I SEA+Cf 
SEA +PT 
Figure 5. Inhibition of SEA-induced increase in 
IL-l-alpha secretion by EC with the use of 
specific inhibitors of signal transduction. 
The values expressed are the mean + SEM 
generated by pooling the data from two 
separate experiments. (CT -cholera toxin; PT-
pertussis toxin) 
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• Control 11.1 SEA II H-7 f2i:J SEA+ H-7 
0 H-8 • SEA+H-8 ~ cr [I SEA+Cf 
E3 PT D SEA+PT 
Figure 6. Effect of the application of specific 
inhibitors of signal transduction on the SEA-
induced increase in TNF-alpha response by 
epidermal cells. The values expressed are 
the mean .±.. SEM generated by pooling the data 
from two separate experiments. 
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secretion of TNF-alpha considerably. The mechanism leading to 
increased TNF-alpha secretion due to such stimulation may or may 
not involve a G-protein and the above mentioned second messengers. 
Effect of Binding Cell Surface Ia Molecules 
with Anti-Ia mAb Prior to Stimulation 
with SEA 
Surface Ia (murine MHC-class-11) molecules were bound by a 1 
h incubation at 37°C with anti-la monoclonal antibody (mAb) prior to 
the addition of SEA to EC suspensions. This was done to investigate 
the route of action of SEA via Ia molecules. After SEA application, the 
cells were further incubated for 24 h before testing the supernatant 
fluids for IL-l-alpha and TNF-alpha. As shown in Figure 7, the 
constitutive IL-l-alpha secretion was significantly lowered but no 
effect was seen on the SEA-induced response when the cell surface 
Ia molecules had been blocked. Nevertheless, the overall SEA-
induced IL-l-alpha level was markedly reduced. Results of the effect 
of adding anti-Ia mAb to EC suspensions on the production of TNF-
alpha were variable and statistically not meaningful, as depicted in 
Figure 8. These results indicated that the mAb and SEA were specific 
for two separate epitopes on the Ia molecules and that binding of the 
mAb down-regulated IL-l-alpha secretion. This shows that the use 
of anti-Ia mAb in some investigations within this study did not 
adversely affect the stimulatory action of SEA. This may also be the 
case with the induction of TNF-alpha as well, but is not supported by 
this study. 
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• Control fa SEA II X-Ia 
~ X-la+SEA 
Figure 7. Effect of binding cell-surface Ia 
molecules with Anti-Ia mAb on SEA-induced IL-l 
-alpha secretion. The values expressed are the 
mean + SEM generated by pooling the data from 
two separate experiments. (X-Ia - anti-Ia 
monoclonal antibody) 
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• Control II SEA 
~ X-la+ SEA 
Ill X-Ia 
Figure 8. Effect of binding cell-surface Ia 
molecules with Anti-Ia mAb on SEA-induced TNF-
alpha secretion. The values expressed are the 
mean + SEM generated by pooling the data from 
two separate experiments. 
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Effect of Depleting Specific EC-Subpopulations 
on Cytokine Production 
LCs, DETCs, or both subpopulations were eliminated from EC 
suspensions by treating ECs with anti-Ia, anti-Thyl, or both. This was 
followed by incubation with rabbit complement. Since the cells did 
not show equal amounts of constitutive IL-l-alpha production 
between the two experiments, these results could not be grouped 
and are presented separately. As shown in Table I, the LC-depleted 
fraction of ECs secreted lower quantities of IL-l-alpha constitutively. 
The results obtained with the DETC-depleted fraction and LC- and 
DETC-depleted fraction were quite variable. 
Consistent with the results of earlier experiments, the SEA-
induced increase in TNF secretion by ECs was statistically 
insignificant. As shown in Figure 9, LC-depleted fractions exhibited 
no significant change in TNF-alpha secretion. The depletion of DETC 
from EC suspensions, however, markedly decreased both constitutive 
and SEA-induced total TNF-alpha secreted by ECs. A similar decrease 
was seen in the EC fractions depleted of both LCs and DETCs. 
These results suggest that LCs are partly responsible for the 
constitutive but not SEA-induced IL-l-alpha secretion, while the 
production or regulation of IL-l secretion by DETCs is inconclusive. 
There is a strong indication that DETCs may either be a source of or 
serve as inducers of constitutive TNF-alpha secretion in the 
epidermis. The presence of DETCs in the LC-depleted fraction 
correlated with lower constitutive and SEA -induced IL-l-alpha when 










Constitutive and SEA-Induced IL-l alpha Secretion* by 
Specific Subpopulation-Depleted Epidermal Cells 
EC+SEA LC depleted LC depleted + SEA DETC depleted 
135 70 102 56 
58 38 50 51 
DETC depleted LC and DETC depleted LC and DETC depleted + SEA 
+SEA 
73 84 114 
51 46 56 















• ~ II EC +SEA II LC depleted 
~ LC depleted + SEA 0 DETC depleted 
• DETC depleted + SEA ~ LC and DETC depleted 
ill LC and DETC depleted + SEA 
Figure 9. TNF-alpha response of epidermal-cell 
suspensions depleted of LC, DETC, or both, to 
stimulation with SEA. The values expressed 
are the mean + SEM generated by pooling 
the data from two separate experiments. 
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data suggest that in the absence of LCs in the epidermis, a product of 
the DETCs may be present that partially inhibits the secretion of IL-
l-alpha by ECs, in contrast to the apparent stimulatory role of DETCs 
in the secretion of TNF-alpha or enhancement of TNF-alpha secretion 
by other cells. 
An Investigation of the Potential Involvement of 
Dendritic Epidermal T -cells (DETC) in 
EC Cytokine Secretion 
A preliminary investigation was conducted to test whether 
Thy-1 + DETCs are involved in a complex intercellular-signalling 
network that modulates EC secretion of IL-l-alpha and TNF-alpha. 
Cell-free supernatant fluid of cultured hybridoma R4-6A2 (anti 
murine IFN-gamma) cells was utilized at a final concentration of 25% 
v/v in the culture medium to block any IFN-gamma that might be 
present. Following 1 h incubation at 37°C with or without the 
antibody, SEA was added to specific groups and the cells were 
incubated for 24 h. Subsequently, the culture supernatant fluids 
were harvested and tested for the two cytokines. No significant effect 
of IFN-gamma on constitutive or SEA-induced IL-l-alpha secretion 
was noticeable (Figure 10). Although SEA-induced TNF-alpha 
secretion remained unaffected, the constitutive TNF-alpha level was 
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• SEA II X-IFN gamma ~ X-IFN gamma + SEA 
Figure 10. Effect of blocking IFN-gamma in 
epidermal cell suspensions on SEA-induced 
secretion of IL-l-alpha. The change in IL-l 
-alpha secretion was calculated by subtracting 
the constitutive IL-l-alpha level from levels 
detected in the treatment groups. The values 
expressed are the mean + SEM. generated by 
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Ia SEA II X-IFN gamma rZJ X-IFN gamma+ SEA 
Figure 11. Effect of blocking IFN-gamma in 
epidermal cell suspensions on SEA-induced 
TNF-alpha secretion. The change in TNF-alpha 
secretion was calculated by subtracting the 
constitutive TNF-alpha level from levels 
detected in the treatment groups. The values 
expressed are the mean + SEM generated 
by pooling the data from two separate 
experiments. 
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Cytokine Secretion by Purified 
Langerhans Cells 
The final set of experiments m this study involved an 
examination of IL-l-alpha and TNF-alpha secretion by purified LCs. 
LCs isolated by biomagnetic separation contained magnetic 
microspheres (beads) attached on the cell surface via Ia molecules. 
The fraction of cells that remained after Ja+ cell removal were 
labelled "other epidermal cells (OECs)" and were used as another 
group in this study. Two concentrations of each of these two groups, 
LC and OEC, were cultured in the presence or absence of SEA. Since 
all our studies utilized ECs at a concentration of 2 X 106 viable 
cells/ml, one group of purified LCs were cultured at 4 X 104 viable 
cells/ml which is 2% of this cell number and represents the normal 
density of LCs in the epidermis. Another group of LCs were cultured 
at a concentration of 5 X 105 viable cells/ml, which was previously 
determined to produce cytokine levels in the lower part of the range 
detectable by the ELISA kits that were used. To be comparable with 
the latter group of LCs, one group of OECs was cultured at 5 X 105 
viable cells/ml while another was cultured at 2 X 106 viable cells/mi. 
Figures 12 and 13 illustrate the results of this study. LCs at 4 X 104 
cells/ml were found to produce negligible amounts of both cytokines. 
As shown in Figure 12, the increase of LC-derived IL-l-alpha (at 5 X 
1 os LC/ml) induced by SEA was insignificant while OECs at either 
concentration exhibited statistically significant increases. The EC 
group, comprising a mixture of the two epidermal cell subpopulations 










• LC @5Xl0(5) fl LC @5X10(5) +SEA 
f?j LC@4X10(4) +SEA 0 OEC@2X10(6). 
~ OEC@5X10(5) mJ OEC @5X10(5) +SEA 
[i] EC @2X10(6) +SEA 
II LC@4X10(4) 
OEC @2X10(6) +SEA 
12] EC @2Xl0(6) 
Figure 12. IL-l-alpha response of purified LC and a 
LC-depleted epidermal-cell population (OEC) to 
stimulation with SEA. The figures in the legend 
indicate the number of cells/mi. The values 
expressed are the mean + SEM generated by 
pooling the data from two separate experiments. 
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• LC @5X10(5) fa LC @5X10(5) +SEA II LC @4X10(4) 
~ LC @4X10(4) +SEA 0 OEC @2X10(6) • OEC @2X10(6) +SEA 
~ OEC@5X10(5) II OEC@5X10(5) +SEA 0 EC @2X10(6) 
D EC @2X1 0(6) + SEA 
Figure 13. TNF-alpha response of purified LC and a 
LC-depleted epidermal-cell population (OEC) to 
stimulation with SEA. The figures in the legend 
indicate the number of cells/mi. The values 
expressed are the mean + SEM generated by 
pooling the data from two separate experiments. 
stimulation with SEA. The analysis of TNF-alpha m these 
experiments, as depicted in Figure 13, did not provide meaningful 
information due to considerable variation between experiments. 
The results of this study indicate that rosetted LCs are capable 
of cytokine secretion and, more importantly, that while isolated LCs 
are not a significant source of the increased IL-l-alpha secretion by 
ECs, OECs may be chiefly responsible for the increase induced by SEA. 
Although the SEA-induced increase in IL-l-alpha secretion by 
purified LCs was statistically insignificant, the possibility still exists 
that the LCs may be partly responsible for this increase in the 
presence of OECs, but subsequently cease this response once they are 
separated from them, such as when LCs migrate out of the epidermal 
compartment en route to the lymph nodes. 
Summary 
Altogether the various investigations m this study have 
revealed the following aspects of the epidermal cell (EC) and 
Langerhans cell (LC) cytokine modulation. It was found that ECs 
constitutively produce IL-l-alpha and TNF-alpha. They increase 
their production of mainly interleukin(IL)-1-alpha, and to a lesser 
extent of tumor necrosis factor(TNF)-alpha, upon stimulation with 
bacterial toxins, especially staphylococcal enterotoxin-A (SEA). The 
application of SEA on the external surface of the skin alters the 
morphology of LCs within the epidermis from a dendritic shape to a 
rounded appearance. The increased secretion of IL-l-alpha by ECs 
stimulated by SEA apparently involves protein kinase C in the 
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molecular intracellular signalling cascade within ECs while the 
constitutive IL-l-alpha secretion is probably induced through the G-
protein-mediated pathway. More specifically, there are indications 
that LCs are partly responsible only for the constitutive secretion of 
IL-l-alpha while other epidermal cells (OECs) are chiefly responsible 
for the SEA-induced response. On the other hand, the dendritic 
epidermal T-cells (DETCs) may either be a source of or serve as 
inducers of constitutive TNF-alpha secretion in the epidermis. 
Furthermore, some results indicate that in the absence of LCs in the 
epidermis, a product of the DETCs may be present that partially 
inhibits the secretion of IL-l-alpha by ECs. Although one 
investigation within this study indicated the potential role of 
interferon(IFN)-gamma (possibly produced by DETC m the 
epidermis) in the induction of constitutive TNF-alpha, but not of 
SEA-induced TNF-alpha and both constitutive and SEA-induced IL-l-
alpha secretion, the possibility cannot be entirely ruled out. Thus the 
potential role of DETCs as regulators of EC-cytokine secretion still 
exists. The findings from this study constitute a fundamental step in 
the ultimate elucidation of cytokine networks within the skin and the 
signalling mechanism(s) following hapten/antigen application on the 




The nature of the stimulus which causes Langerhans cells (LCs) 
to migrate out of the epidermis following exposure to cutaneous 
antigens poses an interesting and yet unresolved question. There are 
several biological mediators that could potentially constitute such a 
stimulus. Since cytokines are known to regulate several immunologic 
mechanisms, epidermal-cell-derived cytokines have been under 
close scrutiny for the last few years. Granulocyte/macrophage colony 
stimulating factor (GM-CSF) was found to increase viability and 
enhance the function of LCs in culture (58,118), and in humans, to 
promote keratinocyte growth and wound healing ( 48). TNF-alpha has 
been shown to maintain LC viability in vitro, but no enhancement of 
LC function was noted (58). IL-l alone, on the other hand, was 
previously found to enhance LC function but not viability when 
combined with GM-CSF (44). 
In addition to maintaining LC viability and function, the 
involvement of cytokines in the phenomenon of LC migration has 
also been recently suggested. Lundqvist and Back ( 1990) discovered 
that a systemic or intracutaneous injection of recombinant IL-l-beta 
caused a decrease in Ia+ dendritic cells in the epidermis of C3H/HeN 
mice (71). Subsequently, Enk et al. (1993) found that such an 
injection of IL-l-beta given to BALB/c mice resulted m 5- to 100-
fold enhancement of mRN A signals for IL-l-alpha, IL-l-beta, 
macrophage inflammatory protein (MIP)-2, IL-10, TNF-alpha, and 
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MHC-class-11 (Ia) molecules, mimicking the changes induced by 
antigens that cause LC depletion (26). Thus they were able to suggest 
that dendritic cell-derived IL-l-beta may play a critical role in the 
initiation of primary immune responses in the skin. The synthesis of 
IL-l-beta mRNA has been demonstrated by other researchers as 
well (74,95). Enk and Katz (1992) had previously reported that the 
secretion of IL-l-beta protein was below the level of detection in 
sensitive bioassays, and by the analysis of mRNA signals showed that 
LCs mainly produced IL-l-beta while keratinocytes were the major 
sources of secreted IL-l-alpha, GM-CSF, MIP-2, and TNF-alpha (28). 
On the other hand, Cumberbatch and Kimber (1992) demonstrated 
that an injection of recombinant munne TNF-alpha into the dermis of 
BALB/c mice leads to the concentration- and time-dependent 
accumulation of dendritic cells m the draining lymph nodes (21 ), 
while GM-CSF was shown to be incapable of stimulating dermal 
dendritic cells in an identical manner. 
Previous studies have shown that staphylococcal superantigens 
are capable of inducing a dose-dependent depletion of LCs from 
murine epidermis (85). The underlying stimulatory signal(s) and 
mechanism(s) may be similar to the situation of LC depletion induced 
by nominal antigens. Since both IL-l-alpha and TNF-alpha are 
produced by keratinocytes (the major EC subpopulation), their 
presence in epidermal cultures is easily detectable by ELISA. Thus 
the purpose of this study was to examine the effect of SEA on the 
production of IL-l-alpha and TNF -alpha by epidermal cells. An 
incubation period of 24 h following SEA application was initially 
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determined to result in the secretion of optimal levels of both 
cytokines (data not shown). 
Lipopolysaccharide (LPS) was originally discovered as the 
endotoxin that induced TNF secretion m bacillus Calmette-
Guerin(BCG)-infected mice during a study of hemorrhagic necrosis of 
transplanted tumors caused by material from gram-negative bacteria 
(14 ). It was found to be toxic for tumors and thus caused their 
necrosis, a function previously attributed to the endotoxin itself. LPS 
is known as a potent non-specific activator of macrophages and 
monocytes (3 ), inducing them to produce cytokines such as TNF and 
IL-l (15). We have found that both LPS and SEA were capable of 
stimulating increased IL-l-alpha secretion. SEA was more potent 
than LPS in this stimulatory capacity. When applied simultaneously, 
SEA and LPS seemed to synergistically induce very high IL-l-alpha 
levels. LPS has previously been found to act in a synergistic fashion 
with IL-l-alpha, TNF-alpha, IFN-gamma, and M-CSF m various 
experimental systems (30, 79,98). Two possibilities might explain the 
tremendous increase of IL-l-alpha under simultaneous stimulation 
with SEA and LPS. The first possibility is that the two toxins may be 
directly synergising through co-stimulation, while the second is that 
the SEA or LPS induced IL-l-alpha synergises with LPS. These 
possibilities could be further be tested by including purified 
recombinant murine IL-l-alpha, both alone and with LPS, as 
additional treatment groups in an identical study. 
TNF-alpha was found to be secreted constitutively m high 
amounts, but much variation was observed between experiments. 
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Thus most of the following discussion focusses on the significant 
findings relevant to IL-l-alpha. 
The binding of Ia ligands to cell surface receptors has 
previously been demonstrated to result in elevated intracellular 
cAMP levels and in the translocation of protein kinase C (PKC) to the 
nucleus in murine B cells (13), and in the secretion of IL-l by human 
monocytes (82). Ia molecules are members of the immunoglobulin 
supergene family which have been described to commonly have src-
type protein tyrosine kinases (PTK) associated with their cytoplasmic 
domains (17). Activation of receptor-coupled PTK triggers a cascade 
of tyrosine phosphorylations of which the first event is the 
phosphorylation of an enzyme (referred to as the effector). This leads 
to the activation of a second messenger, which is then followed by 
several other events (2). 
Previous studies have revealed that H-8, cholera toxin(CT), and 
pertussis toxin(PT) are able to significantly block SEA-induced LC 
depletion from the epidermis (85). This suggests that G-proteins and 
their associated cyclic nucleotide-dependent protein kinases are 
involved in the phenomenon of LC migration. GTP-binding proteins 
(G-proteins) are located near the cytoplasmic end of some cell-
surface receptors and function as signal transducers. G-proteins 
consist of three protein chains - alpha, beta, and gamma, of which the 
critical role in signal transduction is played by the alpha subunit. 
When a ligand-bound receptor binds to a G-protein, the alpha 
subunit is activated. It then dissociates from the beta-gamma dimer 
and binds to an appropriate enzyme (adenylate cyclase or 
phosphoinositide-specific phospholipase C). The activated enzyme 
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then acts as an amplifier and produces a specific second messenger 
(cAMP or protein kinase C) which in turn affects the production of a 
third and perhaps even a fourth messenger that ultimately alters cell 
function or behaviour (1). 
The property of G-proteins that is commonly exploited to study 
their involvement in transmembrane signalling mechanisms is their 
sensitivity to cholera and pertussis toxins. These toxins were used in 
this study because of their ability to inhibit the transduction of a 
signal by ADP-ribosylating specific G-proteins (114). H-8, a specific 
inhibitor of G-protein-associated cyclic-nucleotide-dependent kinases 
( 45) was used in this study to examine the role of these cyclic 
nucleotide-dependent protein kinases. In addition, H-7 was utilized 
in this investigation because of its selective ability to inhibit protein 
kinase C (52). Moreover, the use of this inhibitor in conjunction with 
the others mentioned above was useful in implicating protein kinase 
C as the second messenger (and therefore phospholipase C as the 
effector enzyme) in the SEA-induced stimulus mediated through 
surface Ia molecules causes increased IL-l-alpha secretion by ECs. 
It was found m this study that constitutive IL-l-alpha 
secretion involves a G-protein-mediated-transduction pathway while 
the SEA-induced IL-l-alpha response involves protein kinase C. Both 
the G-protein-mediated pathway and the PTK-mediated pathway 
may involve protein kinase C as the second messenger. If the protein 
kinase C was a part of the G-protein-transduced pathway then H-8, 
cholera toxin, and pertussis toxin should also have, in addition to H-7, 
been able to block the IL-l-alpha response to SEA stimulation. Thus 
it is evident that the SEA-induced signal is transduced via the PTK 
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pathway. Indeed, Chatila and Geha (1993), having reviewed in a 
recent article (17) the work of several other groups, presented a 
scheme for transmembrane signalling in which PTK is shown to be 
associated with the cytoplasmic end of the Ia molecule. The results of 
the present investigation are supported by the work of Fuleihan e t 
a l. (1991) who demonstrated that staphylococcal exotoxins 
(superantigens) induced a transient accumulation of cAMP in HLA-
D R + human B cells (32). But this does not account for the effects of 
bacterial superantigens induced via surface-MHC-class-11 molecules, 
which were shown by the failure of forskolin (a direct activator of 
adenylate cyclase) to reproduce activation events through Ia 
molecules similar to those induced by staphylococcal exotoxins. 
Moreover, the use of HA 1004 (an activator of cAMP-dependent 
protein kinases) to abolish these activation events also proved to be 
a failure (32). These results are particularly interesting in the face of 
a recent finding by Halliday and Lucas ( 1993) that protein kinase C 
transduces the signal for Langerhans' -cell migration from the 
epidermis (39). The fact that G-proteins have been implicated in LC 
depletion from the epidermis (85) indicates that SEA does not 
directly induce LC migration but that it induces a primary mediator 
which may itself, or via secondary mediators, signal the LCs to 
migrate. Whether IL-l-alpha could, in fact, provide such a signal is 
intriguing in view of previous reports of the stimulation of cAMP 
synthesis by IL-l m a variety of cells (1 00) and the involvement of a 
G-protein in the transduction of this stimulus (18). Normal resting 
keratinocytes have been found to express IL-l receptors in low 
numbers in humans (8) while the expression by LC of these receptors 
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has not yet been reported. The use of H-8, cholera toxin(CT), and 
pertussis toxin(PT) apparently did not have any effect on the SEA-
induced increase in IL-l-alpha secretion by EC but did in fact 
significantly lower the total IL-l-alpha levels (see Figure 5). It is 
possible that this overall decrease m IL-l-alpha level was 
responsible for the inhibition of LC depletion following treatment 
with H-8, CT, or PT seen in the study by Pickard and Burnham (85). 
Based on such a possibility the following hypothesis can be 
considered for the induction of Langerhans'-cell migration from the 
epidermis following appropriate stimulation. ECs constitutively 
secrete IL-l-alpha; upon stimulation with SEA, however, the LCs or 
DETCs are activated which results in the production of an unknown 
mediator that induces OECs (mainly keratinocytes) via a protein 
kinase C-dependent signal-transduction pathway to increase the IL-
l-alpha secretion. These increased IL-l-alpha levels, upon exceeding 
a threshold level, provide the migration signal to LCs via a pathway 
mediated by G-proteins. IL-l has previously been shown to provide 
signals to dendritic cells (DC) that enhance responses mediated by 
them (60). 
The study involving the analysis of the IL-l-alpha levels 
following binding of surface-Ia molecules with anti-Ia monoclonal 
antibody (mAb) clarified the binding site of SEA on the Ia molecule. 
This receptor is independent of the mAb binding site. This was 
evident from the observation that SEA was able to induce an increase 
in IL-l-alpha secretion comparable to that of the controls despite the 
EC surface-Ia molecules being bound to the mAb (see Figure 7). This 
experiment also showed that the mAb alone was able to lower 
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constitutive IL-l-alpha secretion, which cannot be explained as yet. 
Although it Is likely that the SEA-induced signals are affected by Ia 
molecules, this mechanism is not confirmed in the present study. It is 
possible that such a signal Is transmitted by other, as yet 
uncharacterized, superantigen receptors. 
An examination of the role of Langerhans cells (LCs) and 
dendritic epidermal T -cells (DETCs) revealed much variation between 
experiments of IL-l-alpha levels. One possible reason for this may 
be the presence of variable numbers of dead cells after complement-
mediated lysis of the specific cell types. Ideally, the removal of dead 
cells prior to treatment application would eliminate such a 
possibility. The experiments in the present study did not employ 
techniques to remove dead cells because of several other 
complications involved in the process. There are no known reports of 
the negative effects of dead cells on cytokine secretion by cells. 
Despite the variation in IL-l-alpha levels, one distinct pattern was 
noted in each experiment. The depletion of LCs from the suspensions 
markedly lowered the constitutive IL-l-alpha levels (see Table I). 
The TNF assay for these experiments showed little variation. Even 
though SEA did not significantly induce increased TNF-alpha 
secretion, the depletion of DETCs either separately or in conjunction 
with LCs resulted in a major decrease in both constitutive and SEA-
induced total TNF-alpha secretion. Based on this, it can be proposed 
that the DETCs are either a source of TNF-alpha In the epidermis or 
that they serve as enhancers of the constitutive secretion of this 
cytokine by other epidermal cells. It was recently found that the 
induction of functional responses in Ia+ cells, such as the secretion of 
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TNF by monocytes, by staphylococcal exotoxins was potentiated by 
the presence of V -beta-compatible T -cells ( 17). In a similar way 
DETCs, which express the products of the V -gamma-3- and V -delta-
1-gene segments, may potentiate TNF-alpha secretion by LCs. This is 
in contrast to observations of Matsue et al. (1992) who reported that 
the depletion of LCs from EC suspensions caused a marked decrease 
m TNF and macrophage inflammatory protein(MIP)-2 (7 4 ). 
To probe the regulatory role of DETCs, a preliminary 
investigation was performed that examined the effect of adding anti-
IFN-gamma to the culture medium pnor to SEA application. The 
purpose of adding anti-IFN-gamma was to block any IFN-gamma 
that may be produced following culture of ECs. IFN-gamma is known 
to activate macrophages (75) and therefore may also affect 
dendritic-antigen-presenting cells such as LCs. It must be stressed 
that this was only a preliminary investigation since the mAb in the 
supernatant fluid of the R4-6A2 hybridoma cell culture was not 
previously titred. Thus the amount of mAb added may not have been 
sufficient to block all IFN-gamma in the medium. However, if it is 
assumed that all the IFN-gamma was in fact blocked, the results 
suggest no apparent regulatory role of DETCs in the secretion of IL-l-
alpha or TNF -alpha by the common T -cell cytokine, IFN -gamma. 
Another possibility that was not tested in this study, is the 
involvement of other T -cell cytokines in the potential role of DETCs. 
T -cells belonging to the type-2 class of helper cells (T H 2 type) are 
known to secrete mainly IL-4, IL-5, and IL-10, while those of the 
type- I class (T H 1 type) secrete mainly IL-2 and IFN-gamma. It is not 
currently known to which class the DETCs belong. Hence there are at 
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least three cytokines of the T H 2 type and at least one more of the 
T H 1 type that would need to be further examined through similar 
studies. There 1s an indication from this investigation that IFN-
gamma is involved in regulating constitutive TNF-alpha secretion. 
This possibility also needs further clarification. 
To extend the study of the role of LCs in EC-cytokine secretion, 
highly purified (approximately 90-95%) Langerhans' -cell populations 
were obtained by biomagnetic separation. This procedure results in 
LCs rosetted by immunomagnetic spheres. Previous studies have 
demonstrated that the adherence of these immunomagnetic spheres 
does not effect LC function ( 42). We have shown that rosetted LCs 
are capable of cytokine secretion following stimulation with SEA. This 
is in agreement with the unpublished findings of Hanau et al. (1988) 
that rosetted LCs retained their capacity to secrete cytokines upon 
stimulation with endotoxin ( 42). Nevertheless, there is the likelihood 
that the absolute amount of cytokines secreted may have been 
altered. Recall that one of the investigations in this study has 
revealed that binding a mAb to Ia molecules caused a decrease in 
IL-l-alpha secretion. Since LC-surface-la molecules were saturated 
with anti-la mAb prior to biomagnetic separation, the IL-l-alpha 
levels seen in purified LCs may be assumed to be far less than those 
attained under normal conditions (that is, in the absence of blocked 
Ia molecules). However, this assumption cannot be made in the case 
of the purified LCs if they are indeed, as indicated by another 
investigation within this study, not a source of SEA-induced IL-l-
alpha. This investigation indicates that OECs, of which keratinocytes 
are the main subpopulation, secrete the majority of IL-l-alpha. This 
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Is supported by previous observations by other laboratories (67). 
When stimulated with SEA, OECs increased their secretion of IL-l-
alpha. This suggests that OECs may have either been induced to 
express surface Ia molecules through which the stimulus was 
transduced, or that SEA may act on cells through additional or 
alternative means which are not yet known. 
In the midst of extensive research gmng on presently on 
staphylococcal superantigens and their effects on the immune 
system, this study is the first to demonstrate that staphylococcal 
enterotoxin-A IS capable of stimulating the secretion of two 
important immunomodulating cytokines by epidermal cells: IL-l-
alpha and TNF-alpha. However, the roles of these cytokines in LC 
depletion by SEA still remain to be elucidated. 
66 
REFERENCES 
1. Alberts, B., Bray, D., Lewis, J., Raff, M., Roberts, K., and Watson, 
J.D. 1989. Molecular Biology of the Cell. Garland Publishing, Inc., 
NY. pp697 -699 
2. Alberts, B., Bray, D., Lewis, J., Raff, M., Roberts, K., and Watson, 
J.D. 1989. Molecular Biology of the Cell. Garland Publishing, Inc., 
NY. pp706-707 
3. Alexander, P., and Evans, R. 1971. Endotoxin and double 
stranded RNA render macrophages cytotoxic. Nature New Bioi., 
232: 76-78 
4. Bergstresser, P.R., and Juarez, D.V. 1984. Detection by 
immunochemical techniques of cell surface markers on 
epidermal Langerhans cells. Methods in Enzymology, 108: 683-
691 
5. Bergstresser, P.R., Toews, G.B., and Streilein, J.W. 1980. Natural 
and perturbed distributions of Langerhans cells: responses to 
ultraviolet light, heterotopic skin grafting, and 
dinitrofluorobenzene sensitization. J. Invest. Dermatol., 75: 73-
77 
6. Bieber, T., Rieger, A., Neuchrist, C., Prinz, J.C., Rieber, E.P., Boltz-
Nitulescu, G., Scheiner, 0., Kraft, D., Ring, J., and Stingl, G. 1989. 
Induction of Fc-epsilon R2/CD23 on human epidermal 
Langerhans cells by human recombinant interleukin 4 and 
gamma interferon. J. Exp. Med., 170: 309-314 
7. Bieber, T. de la Salle, H., Wollenberg, A., Hakimi, J., Chizzonite, 
R., Ring, J., Hanau, D., and de Ia Salle, C. 1992. Human epidermal 
Langerhans cells express the high affinity receptor for 
Immunoglobulin E (Fc-epsilon Rl). J. Exp. Med., 175: 1285-
1290 
8. Blanton, R.A., Kupper, T.S., McDougall, J.K., and Dower, S. 1989. 
Regulation of interleukin 1 and its receptor in human 
keratinocytes. Proc. Natl. Acad. Sci. USA, 86: 1273-1277 
67 
9. Bos, J.D., Das, P.K., and Kapsenberg, M.L. 1990. The skin immune 
system (SIS). In: Bos, J.D. (ed.) 1990, Skin Immune System 
(SIS), CRC Press, Boca Raton, Florida. pp3-8 
10. Breathnach, A.S. 1980. Branched cells in the epidermis: an 
overview. J. Invest. Dermatol., 75: 6-11 
11. Bruynzeel-Koomen, C., Van Wichen, D.F., Toonstra, J., Berrens, L., 
and Bruynzeel, P.L. 1986. The presence of IgE molecules on 
epidermal Langerhans cells in patients with atopic dermatitis. 
Arch. Dermatol. Res., 278: 199-205 
12. Burke, K., and Gigli, I. 1980. Receptors for complement on 
Langerhans cells. J. Invest. Dermatol., 7 5: 46-51 
13. Cambier, J.C., Newell, M.K., Justement, L.B., McGuire, J.C., Leach, 
K.L., and Chen, Z.Z. 1987. Ia binding ligands and cAMP stimulate 
nuclear translocation of PKC in B lymphocytes. Nature, 327: 
629-632 
14. Carswell, E.A., Old, L.J., Kassel, R.L., Green, S., Fiore, N., and 
Williamson, B. 1975. An endotoxin-induced serum factor that 
causes necrosis of tumors (activated macrophage). Proc. Natl. 
Acad. Sci. USA, 72: 3666-3670 
15. Cavaillon, J.M., Fitting, C., and Haeffner-Cavaillon, N. 1990. 
Recombinant C5a enhances interleukin 1 and tumor necrosis 
factor release by lipopolysaccharide-stimulated monocytes and 
macrophages. Eur. J. Immunol., 20: 253-257 
16. Cerami, A., and Beutler, B. 1988. The role of cachectin/TNF in 
endotoxic shock and cachexia. Immunol. Today, 9: 28-34 
17. Chatila, T. and Geha, R.S. 1993. Signal transduction by microbial 
superantigens via MHC class II molecules. Immunol. Rev., 131: 
43-59 
18. Chedid, M., Shirakawa, F., Naylor, P., and Mizel, S.B. 1989. Signal 
transduction pathway for IL-l. Involvement of a pertussis 
toxin-sensitive GTP-binding protein in the activation of 
adenylate cyclase. J. Immunol., 142: 4301-4306 
68 
1 9. Concha, M., Figueroa, C.D., and Caorsi, I. 1988. Ultrastructural 
characteristics of the contact zones between Langerhans cells 
and lymphocytes. J. Pathol., 156: 29-36 
20. Cumberbatch, M., and Kimber, I. 1990. Phenotypic 
characteristics of antigen-bearing cells in the draining lymph 
nodes of contact sensitized mice. Immunology, 71: 404-410 
21. Cumberbatch, M., and Kimber, I. 1992. Dermal tumor necrosis 
factor-alpha induces dendritic cell migration to draining lymph 
nodes, and possibly provides one stimulus for Langerhans' cell 
migration. Immunology, 75: 257-263 
22. Dinarello, C.A. 1989. Interleukin-1 and its biologically related 
cytokines. Adv. lmmunol., 44: 153-205 
23. Dinarello, C.A., Cannon, J.G., Wolff, S.M., Bernheim, H.A., Beutler, 
B., Cerami, A., Figari, I.S., Palladino, M.A., and O'Connor, J.V. 
1986. Tumor necrosis factor (cachectin) is an endogenous 
pyrogen and induces production of interleukin 1. J. Exp. Med., 
163: 1433-1450 
24. Ebling, F.J.G. 1980. Homage to Paul Langerhans. J. Invest. 
Dermatol., 75: 3-5 
25. Elias, J.M. 1987. The Langerhans cell: sentinel of the body's 
immune defense system. I. Morphology and microscopic 
methods of detection. J. Histotech., 10: 121-124 
26. Enk, A.H., Angeloni, V.L., Udey, M.C., and Katz, S.I. 1993. An 
essential role for Langerhans cell-derived IL-l beta in the 
induction of primary immune responses in the skin. J. 
lmmunol., 150: 3698-3704 
27. Enk, A.H., Angeloni, V.L., Udey, M.C., and Katz, S.I. 1993. 
Inhibition of Langerhans cell antigen-presenting function by 
IL-10. J. lmmunol., 151: 2390-2398 
28. Enk, A.H., and Katz, S.I. 1992. Early molecular events in the 
induction phase of contact sensitivity. Proc. Natl. Acad. Sci. USA, 
89: 1398-1402 
69 
29. Epstein, S.P., Baer, R.L., Thorbecke, G.J., and Belsito, D.V. 1991. 
Immunosuppressive effects of transforming growth factor-
beta: inhibition of the induction of Ia antigen on Langerhans 
cells by cytokines and of the contact hypersensitivity response. 
J. Invest. Dermatol., 96: 832-837 
30. Evans, R., Kamdar, S.J., Duffy, T.M., and Fuller, J. 1992. 
Synergistic interaction of bacterial lipopolysaccharide and the 
monocyte-macrophage colony-stimulating factor: potential 
quantitative and qualitative changes in macrophage-produced 
cytokine bioactivity. J. Leukocyte Bioi., 51: 93-96 
31. Flotte, T.J., Murphy, G.F., and Bhan, A.K. 1984. Demonstration of 
T200 antigen on human Langerhans cell surface membranes. J. 
Invest. Dermatol., 82: 535-537 
32. Fuleihan, R., Mourad, W., Geha, R.S., and ChatHa, T. 1991. 
Engagement of MHC-class II molecules by staphylococcal 
exotoxins delivers a comitogenic signal to human B cells. J. 
lmmunol., 146: 1661-1666 
3 3. Gahring, L.C., Buckley, A., and Daynes, R.A. 1985. Presence of 
epidermal cell derived thymocyte activating factor in normal 
human stratum corneum. J. Clin. Invest., 76: 1585-1591 
34. Girolomoni, G., Cruz, P.D., and Bergstresser, P.R. 1990. 
Internalization and acidification of surface HLA-DR molecules 
by epidermal Langerhans cells: a paradigm for antigen 
processing. J. Invest. Dermatol., 94: 753-760 
35. Grabbe, S., Bruvers, S., Gallo, R.L., Knisely, T.L., Nazareno, R., and 
Granstein, R.D. 1991. Tumor antigen presentation by murine 
epidermal cells. J. Immunol., 146: 3656-3661 
3 6. Grabbe, S., Bruvers, S., and Gran stein, R.D. 1994. Interleukin I 
alpha but not transforming growth factor beta inhibits tumor 
antigen presentation by epidermal antigen presenting cells. J. 
Invest. Dermatol., 102: 67-73 
3 7. Green, 1., Stingl, G., Shevach, E.M., and Katz, S.l. 1980. Antigen 
presentation and allogeneic stimulation by Langer hans cells. J. 
Invest. Dermatol., 7 5: 44-45 
70 
38. Groh, V., Yokozeki, H., Yokoyama, W.M., Foster, C.A., Konig, F., 
Brenner, M.B., and Stingl, G. 1988. T cell receptors gamma/delta 
on dendritic cells of the human epidermis (Abstract). J. Invest. 
Dermatol., 90: 565 
39. Halliday, G.M., and Lucas, A.D. 1993. Protein kinase C 
transduces the signal for Langerhans' cell migration from the 
epidermis. Immunology, 79: 621-626 
40. Hammar, S. 1988. Langerhans cells. Pathol. Annu., 23: 293-328 
41. Hanau, D., Fabre, M., Schmitt, D.A., Garand, J.-C., Pauly, G., 
Tongio, M.-M., Mayer, S., and Cazenave, J.-P. 1987. Human 
epidermal Langerhans cells cointernalize by receptor-mediated 
endocytosis "nonclassical" major histocompatibility complex 
class I molecules (T6 antigens) and class II molecules (HLA-DR 
antigens). Proc. Nat!. Acad. Sci. USA, 84: 2901-2905 
42. Hanan, D., Schmitt, D.A., Fabre, M., and Cazenave, J.-P. 1988. A 
method for the rapid isolation of human epidermal Langerhans 
cells using immunomagnetic spheres. J. Invest. Dermatol., 91: 
274-279 
43. Hauser, C., Saurat, J.H., Schmitt, A., Jannin, F., and Dayer, J.M. 
1986. Interleukin 1 is present in normal human epidermis. J. 
Immunol., 136: 3317-3323 
44. Heufler, C., Koch, F., and Schuler, G. 1988. 
Granulocyte/macrophage colony-stimulating factor and 
interleukin 1 mediate the maturation of murine epidermal 
Langerhans cells into potent immunostimulatory dendritic cells. 
J. Exp. Med., 167: 700-705 
45. Hidaka, H., Inagaki, M., Kawamoto, S., and Sasaki, Y. 1984. 
Isoquinoline sulfonamides, novel potent inhibitors of cyclic 
nucleotide dependent protein kinase and protein kinase C. 
Biochemistry, 23: 5036-5041 
46. Hudson, L., and Hay, F.C. 1989. Practical immunology. Blackwell 
Scientific, Cambridge, Massachusetts. pp423-441 
4 7. lnaba, K., Schuler, G., Witmer, M.D., Valinsky, J., Atassi, B., and 
Steinman, R.M. 1986. Immunologic properties of purified 
7 1 
epidermal Langerhans cells: distinct requirements for 
stimulation of unprimed and sensitized T lymphocytes. J. Exp. 
Med., 164: 605-613 
48. Kaplan, G., Walsh, G., Laarni, S.G., Meyn, P., Burkhardt, R.A., 
Abalos, R.M., Barker, J., Frindt, P.A., Fajardo, T.T., Celona, R., and 
Cohn, Z.A. 1992. Novel responses of human skin to intradermal 
recombinant granulocyte/macrophage colony-stimulating 
factor: Langerhans cell recruitment, keratinocyte growth, and 
enhanced wound healing. J.Exp. Med., 175: 1717-1728 
49. Kapsenberg, M.L., Teunissen, M.B.M., and Bos, J.D. 1990. In: Bos, 
J.D. (ed.) 1990, Skin Immune System (SIS), CRC Press, Boca 
Raton, Florida. pp109-124 
50. Katz, S.I., Tamaki, K., and Sachs, D.H. 1979. Epidermal 
Langerhans cells are derived from cells originating in the bone 
marrow. Nature (London), 282: 324-326 
51. Kaushansky, K., Broudy, V.C., Harlan, J.M., and Adamson, J.W. 
1988. Tumor necrosis factor-alpha and tumor necrosis factor-
beta stimulate the production of granulocyte-macrophage 
colony stimulating factor, macrophage stimulating factor, and 
IL-l in vivo. J. Immunol., 141: 3410-3415 
52. Kawamoto, S ., and Hid aka, H. 1984. 1-(5 isoquinoline sulfonyl 
methyl piperizine) (H-7) is a selective inhibitor of protein 
kinase C in rabbit platelets. Biochem. Biophys. Res. Commun., 
125: 258-264 
53. Kimber, 1., and Cumberbatch, M. 1992. Dendritic cells and 
cutaneous immune responses to chemical allergens. Toxicol. 
Appl. Pharmacol., 117: 137-146 
54. Kimber, 1., Kinnaird, A., Peters, S.W., and Mitchell, J.A. 1990. 
Correlation between lymphocyte proliferative responses and 
dendritic cell migration in regional lymph nodes following skin 
painting with contact-sensitizing agents. Int. Arch. Allergy 
Appl. lmmunol., 93: 47-53 
55. Kinnaird, A., Peters, S.W., Foster, J.R., and Kimber, I. 1989. 
Dendritic cell accumulation in draining lymph nodes during the 
72 
induction phase of contact allergy m mice. Int. Arch. Allergy 
Appl. Immunol., 89: 202-210 
56. Knight, S.C., Krejei, J., Malkovsky, M., Colizzi, V., Gautham, A., 
and Asherson, G.L. 1985. The role of dendritic cells in the 
initiation of immune responses to contact sensitizers. I. In vivo 
exposure to antigen. Cell. Immunol., 94: 427-434 
57. Knight, S.C., Bedford, P., and Hunt, R. 1985. The role of dendritic 
cells in the initiation of immune responses to contact 
sensitizers. II. Studies in nude mice. Cell. Immunol., 94: 435-
439 
58. Koch, F., Heufler, C., Kampgen, E., Schneeweis, D., Bock, G., and 
Schuler, G. 1990. Tumor necrosis factor alpha maintains the 
viability of murine epidermal Langerhans cells in culture, but 
in contrast to granulocyte/macrophage colony-stimulating 
factor, without inducing their functional maturation. J. Exp. 
Med., 171: 159-171 
59. Kock, A., Schwarz, T., Kirnbauer, R., Urbanski, A., Perry, P., 
Ansel, J.C., and Luger, T.A. 1990. Human keratinocytes are a 
source for tumor necrosis factor alpha: evidence for synthesis 
and release upon stimulation with endotoxin or ultraviolet 
light. J. Exp. Med., 172: 1609-1614 
60. Koide, S.L., Inaba, K., and Steinman, R.M. 1987. lnterleukin 1 
enhances T -dependent immune responses by amplifying the 
function of dendritic cells. J. Exp. Med., 165: 515-530 
61. Kripke, M.L., Munn, C.G., Jeevan, A., Targ, J.-M., and Bucana, C. 
1990. Evidence that cutaneous antigen presenting cells migrate 
to regional lymph nodes during contact sensitization. J. 
Immunol., 145: 2833-2842 
62. Kuby, J. 1994. Immunology. W.H.Freeman and Co, NY. pp393-
415 
63. Kuby, J. 1994. Immunology. W.H.Freeman and Co, NY. pp417-
443 
64. Larsen, C.P., Steinman, R.M., Witmer-Pack, M., Hankins, D.F., 
Morris, P.J., and Austyn, J.M. 1990. Migration and maturation of 
73 
Langerhans cells in skin transplants and explants. J. Exp. Med., 
172: 1483-1493 
65. Leibl, H., Hutterer, J., Korschan, H., Schuler, G., Tani, M., 
Tschachler, E., Romani, N., Wolff, K., and Stingl, G. 1985. 
Expression of the Ly-5 alloantigenic system on epidermal cells. 
J. Invest. Dermatol., 84: 91-95 
66. Luger, T.A. 1989. Epidermal cytokines. Acta. Derm. Venereol. 
(Stockh.), 69 (suppl 151 ): 61-76 
67. Luger, T.A., and Schwarz, T. 1990. Epidermal cell-derived 
cytokines. In: Bos, J.D. (ed.) 1990, Skin Immune System (SIS), 
CRC Press, Boca Raton, Florida. pp257 -291 
68. Luger, T.A., and Schwarz, T. 1990. Evidence for an epidermal 
cytokine network. J. Invest. Dermatol., 95: 100s-104s 
69. Luger, T.A., Stadler, B.M., Katz, S.I., and Oppenheim, J.J. 1981. 
Epidermal cell (Keratinocyte)-derived thymocyte-activating 
factor (ETAF). J. Immunol., 127: 1493-1498 
70. Luger, T.A., Stadler, B.M., Luger, B.M., Mathieson, B.J., Mage, M., 
Schmidt, J .A., and Oppenheim, J .J. 1982. Murine epidermal cell 
derived thymocyte activating factor resembles murine IL-l. J. 
Immunol., 128: 2147-2152 
71. Lundqvist, E.N., and Back, 0. 1990. IL-l decreases the number 
of Ia+ epidermal dendritic cells but increases their expression 
of Ia antigen. Acta. Derm. Venereol. (Stockh.), 70: 391-394 
72. Macatonia, S.E., Knight, S.C., Edwards, A.J., Griffiths, S., and 
Fryer, P. 1987. Localization of antigen on lymphocyte dendritic 
cells after exposure to the contact sensitizer fluorescein 
isothiocyanate. Functional and morphological studies. J. Exp. 
Med., 166: 1654-1667 
73. March, C.L., Mosely, B., Larsen, A., Cerretti, D.P., Braedt, G., Price, 
V., Gillis, S., Henry, C.S., Kronheim, S.R., Grabstein, K., Conlon, P.J., 
Hopp, T.P., and Cosman, D. 1985. Cloning, sequence and 
expression of two distinct human interleukin-1 complementary 
DNAs. Nature (London), 315: 641- 647 
74 
7 4. Matsue, H., Cruz, P.D., Bergstresser, P.R., and Takashima, A. 
1992. Cytokine expression by epidermal cell subpopulations. J. 
Invest. Dermatol., 99: 42s-45s 
75. Meltzer, M.S., and Nacy, C.A. 1989. Delayed-type 
hypersensitivity and the induction of activated, cytotoxic 
macrophages. In: Paul, W.E. (ed.) 1989, Fundamantal 
Immunology, Raven Press Ltd., NY. p772 
76. Mommaas, A.M., Mulder, A.A., Vermeer, M., Boom, B.W., Tseng, 
C., Taylor, J.R., and Streilein, J.W. 1993. Ultrastructural studies 
bearing on the mechanism of UVB-impaired induction of 
contact hypersensitivity to DNCB in man. Clin. Exp. Immunol., 
92: 487-493 
77. Moodycliffe, A.M., Kimber, 1., and Norval, M. 1992. The effect of 
ultraviolet B irradiation and urocanic acid isomers on dendritic 
cell migration. Immunology, 77: 394-399 
7 8. Mudde, G.C., Van Reijsen, F.C., Boland, G.J., De Gast, G.C., 
Bruijnzeel, P.L.B., and Bruijnzeel-Koomen, C.A.F.M. 1990. 
Allergen presentation by epidermal Langerhans' cells from 
patients with atopic dermatitis is mediated by IgE. 
Immunology, 69: 335-341 
79. Munoz-Fernandez, M.A., Fernandez, M.A., Fresno, M. 1992. 
Synergism between tumor necrosis factor-alpha and 
interferon-gamma on macrophage activation for the killing of 
intracellular Trypanosoma cruzi through a nitric oxide-
dependent mechanism. Eur. J. Immunol., 22: 301-307 
80. Murphy, G.F., Bhan, A.K., Sato, S., Mihm, M.C., and Harrist, T.J. 
1981. A new immunologic marker for human Langerhans cells. 
N. Engl. J. Med., 304: 791-792 
81. Oppenheim, J.J., Kovacs, E.J., Matsushima, K., and Durum, S.K. 
1986. There is more than one interleukin 1. Immunol. Today, 7: 
45-49 
8 2. Palacios, R. 1985. Monoclonal antibodies against human Ia 
antigens stimulate monocytes to secrete interleukin 1. Proc. 
Natl. A cad. Sci. USA, 82: 6652-6656 
75 
83 · Peeler, J.S., and Niederkorn, J.Y. 1986. Antigen presentation by 
Langerhans cells in vivo: donor-derived Ia+ Langerhans cells 
are required for the induction of delayed-type hypersensitivity 
but not for cytotoxic T lymphocyte responses to alloantigens. J. 
Immunol., 136: 4362-4371 
84. Peguet-Navarro, J., Dalbiez-Gauthier, C., Dezutter-Dambuyant, C., 
and Schmitt, D. 1993. Dissection of human Langerhans cell 
allostimulatory function. Modulation of interferon-gamma. Adv. 
Exp. Med. Biol., 329: 205-208 
85. Pickard, S., and Burnham, K. 1993. Unpublished observations. 
86. Reis e Sousa, C., and Austyn, J.M. 1993. Phagocytosis of antigens 
by Langerhans cells. Adv. Exp. Med. Biol., 329: 199-204 
87. Romani, N., Stingl, G., Tschachler, E., Witmer, M.D., Steinman, 
R.M., Shevach, E.M., and Schuler, G. 1985. The Thy-1-bearing 
cell of murine epidermis. A distinctive leukocyte perhaps 
related to natural killer cells. J. Exp. Med., 161: 1368-1383 
8 8. Rowden, G. 1980. Expression of Ia antigens on Langerhans cells 
in mice, guinea pigs, and man. J. Invest. Dermatol., 7 5: 22-31 
8 9. Rowden, G. 1990. Monocytes, macrophages, histiocytes, and 
dendritic cells. In: Bos, J.D. (ed.) 1990, Skin Immune System 
(SIS), CRC Press, Boca Raton, Florida. pp125-157 
90. Rowden, G., Lewis, M.G., and Sullivan, A.K. 1977. Ia antigen 
expression on human epidermal Langerhans cells. Nature 
(London), 268: 247-248 
91. Rowden, G., Misra, B., Highley, H., and Howard, R. 1983. 
Antigens specified by the Tla locus are expressed on the 
surface of murine Langerhans cells. J. Invest. Dermatol., 81: 2-6 
92. Rowden, G., Phillips, T.M., and Delovitch, T.L. 1978. Expression 
of Ia antigens by murine keratinizing epithelial Langerhans 
cells. Immunogenetics, 7: 465-478 
93. Schmitt, D.A., Hanau, D., and Cazenave, J.-P. 1989. Isolation of 
epidermal Langerhans cells. J. Immunogenetics, 16: 157-168 
76 
94. Schuler, G., and Steinman, R.M. 1985. Murine epidermal 
Langerhans cells mature into potent immunostimulatory 
dendritic cells in vitro. J. Exp. Med., 161: 526-546 
9 5. Schreiber, S., Kilgus, 0., Payer, E., Kutil, R., Elbe, A., Mueller, C., 
and Stingl, G. 1992. Cytokine pattern of Langer hans cells 
isolated from murine epidermal cell cultures. J. Jmmunol., 149: 
3525-3534 
96. Schwarz, T., Urbanska, A., Gschnait, F., and Luger, T.A. 1987. 
UV -irradiated epidermal cells produce a specific inhibitor of 
interleukin-1 activity. J. Immunol., 138: 1457-1463 
97. Schwarz, T., and Luger, T.A. 1989. Effect of UV irradiation on 
epidermal cell cytokine production. J. Photochem. Photobiol., 4: 
1-13 
9 8. Sharma, S.A., Olchowy, T.W., Yang, Z., and Breider, M.A. 1992. 
Tumor necrosis factor alpha and interleukin 1 alpha enhance 
lipopolysaccharide-mediated bovine endothelial cell injury. J. 
Leukocyte Bioi., 51: 579-585 
99. Shimada, S., Caughman, S.W., Sharrow, S.O., Stephany, D., and 
Katz, S.I. 1987. Enhanced antigen-presenting capacity of 
cultured Langerhans' cells is associated with markedly 
increased expression of Ia antigen. J. Immunol., 139: 2551-
2555 
100. Shirakawa, F., Yamashita, U., Chedid, M., and Mizel, S.B. 1988. 
Cyclic AMP - an intracellular second messenger for interleukin 
1. Proc. Natl. Acad. Sci. USA, 85: 8201-8205 
101. Silberberg-Sinakin, 1., and Thorbecke, G.J. 1980. Contact 
hypersensitivity and Langer hans cells. J. Invest. Dermatol., 7 5: 
61-67 
102. Steinman, R.M. 1988. Cytokines amplify the function of 
accessory cells. Immunol. Lett., 17: 197-202 
103. Stingl, G., Katz, S.I., Clement, L., Green, 1., and Shevach, E.M. 
1978. Immunologic functions of !a-bearing epidermal 
Langerhans cells. J. Immunol., 121: 2005-2013 
77 
104. Stingl, G., Tamaki, K., and Katz, S.I. 1980. Origin and function of 
epidermal Langerhans cells. Immunol. Rev., 53: 149-174 
105. Stingl, G., Wolff-Schreiner, E.C., Pichler, W.J., Gschnait, F., Knapp, 
W ., and Wolff, K. 1977. Epidermal Langer hans cells bear Fe and 
C3 receptors. Nature (London), 268: 245-246 
106. Streilein, J.W. 1978. Lymphocyte traffic, T-cell malignancies 
and the skin. J. Invest. Dermatol., 71: 167-171 
107. Streilein, J.W. 1985. Circuits and signals of the skin associated 
lymphoid tissues (SALT). J. Invest. Dermatol., 85: 10s-13s 
108. Streilein, J.W. 1990. Skin-associated lymphoid tissues (SALT): 
the next generation. In: Bos, J.D. (ed.) 1990, Skin Immune 
System (SIS), CRC Press, Boca Raton, Florida. pp25-48 
109. Streilein, J.W., Toews, G.B., and Bergstresser, P.R. 1980. 
Langerhans cells: functional aspects revealed by m vivo 
grafting studies. J. Invest. Dermatol., 7 5: 17-21 
110. Sugarman, B.J., Aggarwal, B.B., Hass, P.E., Figari, I.S., Palladino, 
A.M., and Shepherd, H.M. 1985. Recombinant tumor necrosis 
factor-alpha: Effects on proliferation of normal and 
transformed cells in vitro. Science, 230: 943-945 
111. Tamaki, K., Sting!, G., Gullino, M., Sachs, D.H., and Katz, S.l. 1979. 
Ia antigens in mouse skin are predominantly expressed on 
Langerhans cells. J. Immunol., 123: 784-787 
112. Thorbecke, G.J., Silberberg-Sinakin, I. and Flotte, T.J. 1980. 
Langerhans cells as macrophages in skin and lymphoid organs. 
J. Invest. Dermatol., 7 5: 32-43 
113. Toews, G.B., Bergstresser, P.R., and Streilein, J.W. 1980. 
Epidermal Langerhans cell density determines whether contact 
hypersensitivity or unresponsiveness follows skin painting 
with DNFB. J. lmmunol., 124: 445-453 
114. Ui, M. 1990. G proteins identified as pertussis toxin substrates. 
In: Naccache, P.H. (ed.) 1990, G Proteins and Calcium Signalling, 
CRC Press, Boca Raton, Florida. pp3-27 
78 
115. Van Lambalgen, R., and Wauben-Penris, P.J.J. 1989. Concepts in 
immunodermatology. Acta. Derm. Venereol. (Stockh.), 
69(suppl.151): 55-60 
116. Wang, B., Rieger, A., Kilgus, 0., Ochiai, K., Maurer, D., Fodinger, D., 
Kinet, J.-P., and Stingl, G. 1992. Epidermal Langerhans cells 
from normal human skin bind monomeric IgE via Fc-epsilon RI. 
J. Exp. Med., 175: 1353-1365 
117. Welsh, E.A., and Kripke, M.L. 1990. Murine Thy-1 + dendritic 
epidermal cells induce immunologic tolerance in vivo. J. 
lmmunol. 144: 883-891 
118. Witmer-Pack, M., Olivier, W., Valinsky, J., Schuler, G., and 
Steinman, R.M. 1987. Granulocyte/macrophage colony-
stimulating factor is essential for the viability and function of 
cultured murine epidermal Langerhans cells. J. Exp. Med., 166: 
1484-1498 
119. Wolff, K., and Stingl, G. 1983. The Langerhans cell. J. Invest. 
Dermatol., 80: 017s-021s 
120. Wood, E.J., and Bladon, P.T. 1985. The Human Skin. Studies in 




CYTOKINES FOUND IN THE SKIN 
CYTOKINE 




TNF (-alpha, -beta) 
IFN 
G-CSF, M-CSF, GM-CSF 




Several cell types 
T H cells, NK cells, 
mast cells 
monocytes, macro-


















Co-stimulates activation of T-
cells; enhances activity of NK 
cells; increases expression of 
adhesion molecules on endo-
thelial cells; chemoattractant for 
macrophages and neutrophils 
Supports growth and 
differentiation 
Stimulates antibody secretion; 
induces secretion of acute phase 
proteins 
Chemoattractant for neutrophils 
cytotoxic to tumor cells; Induces 
cytokine secretion by cells 
Inhibits viral replication; 





macrophages and monocytes; 
induces increased IL-l prod-
uction; promotes wound healing 
Mitogen for fibroblasts and 
endothelial cells 
Increases MHC-class-11 
expression on macrophages; 














Inhibitor of IL-l 
ABBREVIATIONS: IL- interleukin; TNF- tumor necrosis factor; IFN-
interferon; G-CSF- granulocyte colony-stimulating factor; M-CSF- macrophage 
colony-stimulating factor; GM-CSF- granulocyte/macrophage colony-
stimulating factor; TGF- transforming growth factor; bFGF- basic fibroblast 




Candidate for the degree of 
Master of Science 
Thesis: MODULATION OF EPIDERMAL CELL CYTOKINE SECRETION BY 
STAPHYLOCOCCAL ENTEROTOXIN-A 
Major Field: Microbiology, Cell, and Molecular Biology 
Biographical: 
Personal Data: Born in Hyderabad, India, On September 18, 1970, the son 
of Shanta and V. Linga Moorthy. 
Education: Graduated from the Hyderabad Public School, Hyderabad, 
India, in May 1988; received Bachelor of Science degree in 
Biology from Saint Mary's University, Halifax, Canada, in October 
1992; completed the requirements for the Master of Science 
degree at Oklahoma State University in July 1994. 
Professional Experience: Teaching Assistant, Department of Biology, 
Saint Mary's University, Canada, September 1991 to April 1992; 
Teaching Assistant, Department of Microbiology and Molecular 
Genetics, Oklahoma State University, August 1992 to December 
1993; Research Assistant, Department of Microbiology and 
Molecular Genetics, Oklahoma State University, January 1994 to 
July 1994. 
Affiliation: American Society for Microbiology. 
Fellowships and Awards: The Edward A. Grula Distinguished Graduate 
Fellowship, 1993-94, Oklahoma State University; the Cora Downs 
Award, 1994, Missouri Valley Branch of the American Society for 
Microbiology. 
